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Abstract 
 
 Background: Genital herpes is one of the most common sexually transmitted infections in 
the United States.  As genital herpes is incurable and contagious, individuals with genital herpes 
face the decision to disclose their status to potential sexual partners with each new relationship 
formed.  Such disclosure places individuals with genital herpes in a position to face rejection, 
which is commonly reported as one of the most concerning aspects of having genital herpes.  
The present study seeks to further understand the nature of genital herpes disclosure by 
addressing two core aims: 1) to understand determinants of and reasons for disclosure and non-
disclosure and 2) to explore the relationship between past partner reactions to a disclosure and 
future intentions to disclose.  Methods: Data on genital herpes disclosure experiences were 
collected via an online questionnaire, which was distributed through a variety of online channels 
including social media websites and email lists.  Individuals who self-identified as having genital 
herpes and were 18 years and older were eligible for participation.  Results:  In examining Aim 
1, the majority of participants (80.4%) disclosed to their last sexual partner.  Age, relationship 
length, type of relationship, and expectations of a partner’s response were significantly 
associated with the decision to disclose at the bivariate level.  Expectations of a partner’s 
reaction (AOR = .20, 95% CI .074-.539) and relationship type (AOR = 8.31, 95% CI 1.96-35.32) 
remained significant in multivariable modeling, explaining 45.2% of the variance in disclosure. 
Respondents who reported being in socially committed relationships and those who expected 
more positive partner reactions to a disclosure were more likely to disclose.  Disclosure was also 
significantly associated with many romantic relationship building activities (e.g., establishing an 
vi 
 
exclusive relationship) but largely not associated with the sexual progression of a relationship.  
The decision to disclose was commonly multi-faceted, with the majority of participants reporting 
more than one reason that they did or did not disclose.  Primary reasons for  disclosure included I 
wanted to be honest, To protect my partner from getting herpes, and It’s my partner’s right to 
know, while the most common reasons for non-disclosure were I was concerned my partner 
would react badly, I was ashamed, and I was concerned that my partner would have rejected me.  
Regarding Aim 2, participants reported low levels of negative reactions and perceived rejection 
in response to their last disclosure experience.  Intentions to disclose in the future were high 
among those who anticipated future sex partners.  Discussion:  The decision to disclose is often 
multi-faceted, and relationship characteristics play a key role in the decision to disclose.  Among 
those who did disclose in this study, the majority did not report negative repercussions, including 
bad partner reactions and rejection.  Future studies should examine if individuals are able to 
accurately assess potential partner reactions in order to better understand the differences between 
those who choose not to disclose and those who choose to disclose but experience a negative 
partner reaction or rejection. 
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Introduction 
Purpose 
The purpose of this dissertation is three-fold.  The first goal is to examine 
individual and partner level characteristics associated with genital herpes disclosure and 
non-disclosure.  The second goal is to build on existing qualitative studies to understand 
partner reactions to a genital herpes disclosure using quantitative methodology, 
specifically highlighting associations with perceptions of rejection.  Finally, this study 
seeks to understand how partner reactions to disclosure, including rejection, are 
associated with future intentions to disclose.  Together, a more comprehensive picture of 
the role of rejection in the disclosure process is formed.   
Dissertation Format 
 A manuscript-style format is used for this dissertation.  This section introduces 
the purpose of the study and contains a comprehensive review of the literature.  Section 2 
contains the first manuscript, which explores individual and relationship characteristics 
that are associated with genital herpes disclosure.  This manuscript will be submitted to 
the Journal of Health Psychology.  Section 3 contains the second manuscript, which 
addresses how past partner reactions to a genital herpes self-disclosure are related to 
future intentions to disclose. The second manuscript will be submitted to the American 
Journal of Health Behavior after additional research is conducted to expand on existing 
dissertation findings. 
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Comprehensive Literature Review 
Sexually Transmitted Infections 
 Some of the most prevalent communicable diseases in the U.S. are sexually 
transmitted (Centers for Disease Control and Prevention, 2011).  Discussed as either 
sexually transmitted disease (STDs) or sexually transmitted infections (STIs),1 infections 
that are sexually transmitted are a considerable public health problem.  In 1997, the 
Institute of Medicine identified sexually transmitted infections as the “the hidden 
epidemic” and called for a coordinated national approach to reducing the burden of STIs 
in the U.S. (Eng & Butler, 1997). More than a decade later, STIs persist as a public health 
priority. 
The total public health burden of STIs is difficult to capture. The Centers for 
Disease Control and Prevention (CDC) (2010b) estimates that approximately 19 million 
new cases of chlamydia, gonorrhea, and syphilis occurred in 2009 accruing over $16.4 
billion dollars in direct medical costs.  However, chlamydia, gonorrhea, and syphilis are 
just some of the many infections and diseases that fall under the larger umbrella of 
sexually transmitted infections.  These numbers fail to capture other prominent STIs 
including viral STIs such as human papillomavirus (HPV) and genital herpes, which are 
not curable (Centers for Disease Control and Prevention, 2010a). 
Genital Herpes 
Herpes simplex virus (HSV) is a common, incurable skin infection (Centers for 
Disease Control and Prevention, 2012a).  Usually referred to as herpes, HSV can 
                                                          
1 For the purposes of this dissertation, the term sexually transmitted infection (STI) will be used. 
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manifest on many areas of the body but is most commonly found around the mouth and 
the genital region (Centers for Disease Control and Prevention, 2010a).  Herpes is caused 
by two types of the herpes simplex virus: HSV-1 and HSV-2.  Despite few differences 
between HSV types, outbreak location on the body can result in serious social 
repercussions.  HSV on the mouth, generally attributed to HSV-1, is considered 
commonplace.  Referred to as “cold sores” or “fever blisters,” outbreaks are considered 
annoying and unattractive but do not carry an overly negative connotation (Posner, 2000).  
On the other hand, genital herpes is one of the most stigmatized diseases in the U.S. 
(Posner, 2000).   
National statistics examine HSV-2 seroprevelance to estimate the prevalence of 
genital herpes in the U.S.  Data from the National Health and Nutrition Examination 
Survey (NHANES) suggest that the prevalence of genital herpes declined from 21% in 
the 1988-1994 cycle to 17% in the 1999-2004 cycle (Xu et al., 2006) and leveled off to 
16.2% in the 2005-2008 cycle (Xu, Sternberg, Gottlieb, Berman, & Markowitz, 2010).  
However, HSV-2 seroprevalence as the indicator of population genital herpes 
underestimates the actual prevalence of genital HSV (Centers for Disease Control and 
Prevention, 2012b).  Though presence of HSV-2 antibodies almost always indicate 
genital infection (Centers for Disease Control and Prevention, 2010a), HSV-1, 
historically associated with oral herpes, is a growing contributor to genital herpes cases 
(Lafferty, Downey, Celum, & Wald, 2000; C. M. Roberts, Pfister, & Spear, 2003; Wald, 
2006).  The CDC (2006) suggests that up to 50% of genital herpes cases could be due to 
HSV-1.  Conservative estimates report that one in five Americans have genital herpes 
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based on HSV-2 seroprevalence (Centers for Disease Control and Prevention, 2006), 
which makes HSV one of the most prevalent STIs in the U.S.  
According to the CDC, individuals with genital herpes experience the virus in 
different ways (Centers for Disease Control and Prevention, 2010a).  Most individuals 
with genital herpes do not experience symptomatic outbreaks, typically characterized by 
painful sores in the genital region.  Some individuals may not recognize the symptoms 
expressed as genital herpes because they are mild, including genital itching, redness, or 
flu-like symptoms rather than sores.  Other individuals may have an initial symptomatic 
first episode of genital herpes and not present with symptoms again.  The first episode of 
genital herpes tends to be the worst.  Over time, outbreaks often become less frequent.  
For most, genital herpes is more of an annoyance from a physical standpoint (Green, 
2004). 
However, genital herpes can have more serious consequences regarding physical 
health, including increased risk for HIV acquisition, transmission to the eyes, and 
neonatal transmission.  HSV-2 increases the risk for HIV acquisition (Holmberg et al., 
1988).  According to a meta-analysis of longitudinal HIV studies, HSV-2 increased the 
relative risk of HIV infection by three fold in both men and women in the general 
population (Freeman et al., 2006).  HSV can also be spread to the eyes, known as herpes 
simplex keratitis or eye herpes, and potentially cause blindness (Farooq & Shukla, 2012).  
Transmission of HSV from mother to child during pregnancy or delivery can cause 
serious health effects.  Neonatal herpes can result in infant mortality (Brown et al., 1997; 
Handel, Klingler, Washburn, Blank, & Schillinger, 2011). However, neonatal herpes is 
rare.  Studies suggest the prevalence of neonatal herpes ranges depending on region of 
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the US and study methodology (Brown et al., 2003; Mahnert, Roberts, Laibl, Sheffield, & 
Wendel, 2007; Whitley, Davis, & Suppapanya, 2007).  According to a 2006 population 
based study, the rate of neonatal herpes was 9.6 per 100,000 live births (Flagg & 
Weinstock, 2011).  The risk of serious complications as a result of maternal HSV is 
highest for women who newly acquire HSV during the third trimester of pregnancy 
(Brown et al., 1997; Brown et al., 2003; Centers for Disease Control and Prevention, 
2010a).  For those with recurrent genital herpes, a cesarean section is advised only if 
visual symptoms of genital herpes are present at the time of delivery (Centers for Disease 
Control and Prevention, 2010a). 
Studies have consistently shown that the social aspects of having HSV are 
considerably more burdensome than the physical manifestations of the virus (Green et al., 
2003; Melville et al., 2003).  Negative psychosocial consequences, including depression 
(Beauman, 2005), anxiety (Beauman, 2005; Oster & Cheek, 2008), feelings of 
unworthiness (Newton & McCabe, 2008b), decreased feelings of sexual attractiveness 
(Mindel, 1993; Newton & McCabe, 2008b), and fear (Lee & Craft, 2002; Mindel, 1993) 
have been associated with a genital herpes diagnosis.  The most frequent consequence of 
a herpes diagnosis is a reduction or complete withdrawal from sexual activity (American 
Social Health Association, 2000).  In general, a negative stigma is attached to having an 
STI. Dr. Anna Wald, one of the leading experts in genital herpes research, told The New 
York Times that “Herpes has a stigma attached to it that even H.I.V. doesn’t have 
anymore.” (Sabo, 2010).  Individuals indicate that living with the stigma associated with 
herpes is hardest part of having the disease (Lee & Craft, 2002; Melville et al., 2003; 
Mindel, 1993; Richards, Krantz, Selke, & Wald, 2008).  Herpes symptoms can be treated, 
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but herpes cannot be cured (Richards et al., 2008).  As a result, herpes stigma remains 
with someone for life.   
Transmission of genital herpes is complex. Genital herpes transmission is 
commonly described as skin-to-skin transmission, though HSV can be spread 
through lesions, mucosal surfaces, genital secretions, or oral secretions (Centers for 
Disease Control and Prevention, 2012b).  Iconic symptoms of genital herpes such as 
sores or lesions do not need to be present to spread the virus.  Many individuals with 
HSV do not exhibit symptoms of the virus, yet they can still transmit HSV to a partner 
(Centers for Disease Control and Prevention, 2012b).  Asymptomatic shedding is 
believed to occur up to 20% of days (Centers for Disease Control and Prevention, 2012a; 
Tronstein et al., 2011). Individuals without classic symptoms of HSV are reportedly 
responsible for the majority of new genital HSV cases (Centers for Disease Control and 
Prevention, 2012b).  Typically these individuals are not aware they have the virus. 
Public Health Strategies 
 A combination of strategies is endorsed by the public health community to reduce 
the burden of genital HSV in the U.S.  As with other STIs, limiting the number of sexual 
partners is one safer sex strategy recommended (Centers for Disease Control and 
Prevention, 2010a).  Some experts have suggested that this strategy is less likely to be 
effective in HSV acquisition as opposed to other STI transmission because herpes 
transmission occurs more often in relationships regarded as monogamous and serious 
(Wald et al., 2006).   Unlike infections such as gonorrhea and chlamydia, genital herpes 
is not reflective of high partner change necessarily (Corey & Handsfield, 2000).  
Additionally, reduction in sexual activity was low even among individuals who suspected 
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they had genital herpes (Crosby, Head, Moore, & Troutman, 2008).  Though remaining in 
a monogamous relationship with someone who is uninfected remains a positive strategy 
for HSV transmission (Centers for Disease Control and Prevention, 2010a), efforts at 
reducing partners may not prove effective at reducing HSV burden. 
 The CDC reported that male condoms could provide some protection against 
HSV transmission (Centers for Disease Control and Prevention, 2010).  Studies have not 
been able to determine the exact role of condoms in HSV transmission.  This is due to a 
number of factors including correct and consistent condom use, the transitory nature of 
HSV, and the inability for male condoms to cover all areas that might be able to transmit 
the herpes virus.  A pooled analysis of six prospective studies examining HSV-2 
transmission found that individuals using male condoms 100% of the time had a 30% 
lower risk of acquiring HSV-2 (Martin, Krantz, Gottlieb, & et al., 2009).  Though 
providing some protection, the study concluded that the protection from HSV-2 was 
much lower than protection from other STIs (Martin et al., 2009).  As such, male 
condoms are just one of the many tools recommended to reduce HSV transmission. 
 In addition to behavioral strategies, pharmaceutical strategies are also 
recommended to reduce HSV transmission.  Three medications have been approved to 
reduce the activation of HSV when used as suppressive therapy (Centers for Disease 
Control and Prevention, 2010).  Suppressive therapy has been found to reduce the 
number of outbreaks by 70-80% among individuals with frequent outbreaks (Centers for 
Disease Control and Prevention, 2010a). Once-daily valacyclovir reduced the likelihood 
of HSV-2 transmission among heterosexual, monogamous couples (Corey et al., 2004).  
Approved medicines for suppressive treatment also reduced the number of days an 
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individual with HSV sheds virally without an outbreak, reducing the number of days a 
partner is at risk for transmission (Leone, Warren, Hamed, Fife, & Wald, 2007; Mertz, 
2008).  However, this strategy can be costly due to the need to buy medication for daily 
use.  It also works best for individuals with recurrent genital herpes outbreaks and less so 
for individuals with infrequent symptoms (Centers for Disease Control and Prevention, 
2010a). 
 A fourth strategy includes the role of asymptomatic HSV screening.  This is 
perhaps the most controversial strategy suggested in the fight against HSV proliferation; 
experts in the field of genital herpes research are divided as to the role asymptomatic 
testing should play in the fight against genital herpes (The New York Times, 2010).  
Those in favor of asymptomatic HSV testing highlight that HSV is most commonly 
transmitted by someone who is unaware that they have genital HSV (Wald et al., 2006).  
Therefore, identification of asymptomatic individuals is an important component of 
reducing genital herpes spread.  Additionally, recent advancements in type specific IgG 
HSV anti-body tests have increased accuracy of asymptomatic HSV testing diagnoses 
(Ashley, 2002).  Proponents have highlighted that trauma associated with symptomatic 
positive tests results are often acute with very little impact on long term mental health 
outcomes  (Miyai, Turner, Kent, & Klausner, 2004; Richards et al., 2007; Rosenthal et 
al., 2006; Smith et al., 2000).  Those who oppose HSV serologic testing have argued that 
although global measures of mental health status often do not indicate clinical levels of 
anxiety or depression after a positive serological test, there are numerous negative 
psychosocial impacts to a positive genital herpes test result (Mark et al., 2008; Swanson, 
Dibble, & Chenitz, 1995).  Additionally, a positive test result cannot determine where on 
9 
 
the body the HSV infection exists, so it provides an unclear plan for risk reduction 
without identifiable symptoms (Nahmias, 2002).  Despite increased testing accuracy 
using IgG antibody testing, IgG antibodies take time to develop and test results have a 
high chance of a false negative in the first few weeks of infection (Wald & Ashley-
Morrow, 2002).  Behavioral studies have indicated that individuals who are 
asymptomatic with a positive HSV test result are unlikely to engage in risk reduction 
measures after a diagnosis, such as condom use and limiting partners (Crosby, Head, 
DiClemente, Meyerson, & Troutman, 2008).  As a result of these factors, current CDC 
recommendations do not call for routine antibody testing for HSV in the general 
population (Centers for Disease Control and Prevention, 2010).  Instead, CDC 
recommendations for HSV testing are nuanced.  According to the 2010 Sexually 
Transmitted Disease Treatment Guidelines, “Type-specific HSV serological assays might 
be useful in the following scenarios: 1) recurrent genital symptoms or atypical symptoms 
with negative HSV cultures; 2) a clinical diagnosis of genital herpes without laboratory 
confirmation; or 3) a partner with genital herpes. HSV serologic testing should be 
considered for persons presenting for an STI evaluation (especially for those persons with 
multiple sex partners), persons with HIV infection, and MSM at increased risk for HIV 
acquisition” (p. 21). 
Unlike testing, disclosure of one’s genital herpes status to a partner has been 
largely embraced by the public health professionals as a strategy to reduce transmission.  
Current STD treatment guidelines recommend that “All persons with genital HSV 
infection should be encouraged to inform their current sex partners that they have genital 
herpes and to inform future partners before initiating a sexual relationship”  (Centers for 
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Disease Control and Prevention, 2010, p. 23).  For advice on how to cope with a herpes 
diagnosis and how to navigate romantic relationships in the future, the CDC directs 
individuals to the American Social Health Association (ASHA) (Hook & Leone, 2006).  
On the ASHA website in a section dedicated to relationships, ASHA has a segment titled 
“How will a partner react?”  This segment of the ASHA website states, 
“Some may overreact. Some won't bat an eye. Since many people have genital 
herpes or have heard about it, many people won't be shocked or surprised. 
From the stories that we’ve heard at the Herpes Resource Center, most people 
will react well, and will appreciate your honesty and respect for the 
relationship and their wellbeing. While a negative reaction is possible, this 
doesn’t necessarily mean a bad ending. If that person values you as an 
individual and is interested in a relationship, something as minor as herpes 
shouldn’t stand in the way. If it does, then that person obviously wasn’t a 
good fit in the first place. 
 
Whatever happens, try to be flexible. Give your partner time to respond, think 
about what you've said and absorb the information. Remember when you first 
found out? It took you time to adjust, too.  
 
You don't have to be overly concerned about protecting a partner's feelings. 
And, you may want to reconsider a relationship where you have to do all the 
emotional work. A safer sex discussion might help you find out if this partner 
is a good candidate for your love and attention.  
 
A few people are going to react negatively. It won't matter what you say or 
how you say it. Remember, these people are the exception not the rule. If a 
partner decides not to pursue a relationship with you because you have 
herpes, it is best to know this now. There are many people who will be 
attracted to you for who you are--with or without herpes.  
 
Most people react well. They appreciate your approach, honesty and maturity 
in addressing an important health issue. Remember to put herpes into 
perspective: it is an annoying, recurrent skin condition that is treatable and 
manageable--no more, no less.”  (Lo, 2006) 
 
However, this information is unsubstantiated by research and directly contradicts 
fears of individuals with genital herpes illuminated by the literature.  
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Disclosure in the Broader STI Literature 
Disclosure is a subset of the broader partner notification literature.  Partner 
notification has two primary operational practices. The first use for “partner notification” 
is the act of telling potential sexual partners of infection status prior to engaging in 
intimate acts, also commonly referred to as disclosure (Centers for Disease Control and 
Prevention, 2006).  This type of partner notification is primarily associated with incurable 
STIs.  This prospective form of partner notification allows the potential sexual partner to 
make an informed decision about engaging in sexual contact.  The second use of partner 
notification is “contact tracing” (Centers for Disease Control and Prevention, 2006).  
Contact tracing is the notification of previous sexual partners about an STI diagnosis 
either by the patient or the provider (Boskey, 2008).  Often, public health agencies will 
assist in this process for more severe reportable diseases, such as syphilis.  Contact 
tracing attempts to contact and treat retrospectively the sexual partners named by the 
index patient, the patient who initially presents for treatment.   
Despite the varying definitions of partner notification, it is clear that it has two 
goals; 1) to inform individuals that they have been or could be potentially infected; and 2) 
to stop the chain of transmission.  Whereas the first goal can be completed successfully 
regardless of the type of STI, achieving the second goal follows a more ambiguous path.  
The Centers for Disease Control and Prevention (2006) concluded that there was a 
“paucity” of research to indicate that partner notification reduces risk taking behaviors or 
disease incidence, concluding that partner notification may not reduce prevalence at a 
population level.  Additionally, studies that examine partner notification often did not 
measure behavioral and disease prevention outcomes (Green, 2004; Melville et al., 2003; 
12 
 
Newton & McCabe, 2008a).  Programmatic successes were measured on the basis of 
successful notification.  However, notification does not necessarily translate into testing 
or treatment. 
Cited benefits of partner notification with respect to disclosure range from 
fulfilling perceived moral obligations to preventing disease.  Most benefits do not have a 
firm grounding in research, but rather in public opinion and support.  A commonly cited 
benefit of partner notification is honesty (American Social Health Association, 2009; 
Green et al., 2003; Rhode Island Department of Health, 2009).   The position that it is 
important to be an honest and forthright person when engaging in sexual activity, because 
it is the responsible thing to do, is embraced as a part of responsible sexuality.  Another 
cited benefit is respect for others’ health.  Notifying potential partners demonstrates a 
level of respect for their health and a desire to allow individuals to make a decision 
regarding sexual activity based on potential risks (American Social Health Association, 
2009).  Partner notification has the potential to reduce disease incidence by breaking the 
chain of transmission (Rhode Island Department of Health, 2009).  Identifying and 
treating individuals reduces chances of unknowingly continuing to spread the infection.  
Notifying a partner could reduce negative consequences of contracting an infection if 
promptly managed.  For instance, knowledge of chlamydial infection and subsequent 
treatment reduces risk of pelvic inflammatory disease (Centers for Disease Control and 
Prevention, 2007).  Only the last benefit of disclosure addresses disease burden with little 
evidence of its efficacy in doing so (Centers for Disease Control and Prevention, 2010a). 
Appropriate Parallels to Genital Herpes in the Broader Disclosure Literature 
13 
 
 Many aspects of the broader public health strategies and implications regarding 
partner notification do not readily apply to the genital herpes paradigm.  Unlike curable 
STIs, partner tracing is not an effective strategy at reducing HSV burden because herpes 
cannot be cured.  Therefore, disclosure comparisons are not parallel with common 
infections such as gonorrhea, chlamydia, or the less common syphilis.  Unlike HIV, 
which can affect any aspects of one’s life and health, disclosure to individuals outside of 
a sexual relationship context is often unnecessary and uncommon unless seeking 
emotional support or identity confirmation among individuals with genital herpes (Lee & 
Craft, 2002).  Genital herpes disclosure occurs most frequently within sexual 
relationships (Patrick, Rosenthal, Stanberry, Hurst, & Ebel, 2004).  HIV does not provide 
an appropriate parallel because knowledge of one’s HIV status also provides a clear 
prevention strategy when disclosing through the correct and consistent use of condoms; 
the benefits of condom use are less pronounced among individuals with genital herpes 
(Centers for Disease Control and Prevention, 2010a).  Disease severity also eliminates 
comparisons in the broader STI literature.  The potential severity of HIV and cancerous 
types of HPV do not align with the generally mild and transitory nature of genital herpes.  
Genital herpes typically has little to no effect on an individual’s overall physical health 
and rarely evolves into serious disease in immunocompetant individuals (Centers for 
Disease Control and Prevention, 2010a).  Rather it is the social and emotional aspects of 
the infection that are most troubling (Green, 2004).  Therefore, the closest parallel to 
genital herpes in the broader literature is experiences with genital warts.  Genital herpes 
and genital warts are both fairly low risk, incurable skin infections (Centers for Disease 
Control and Prevention, 2010a).  Additionally both can be visible and share a mode of 
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transmission through skin-to-skin contact.  Most importantly, the nature of disclosure is 
similar between these two STIs.  Therefore, I will explore the genital herpes and genital 
wart literature simultaneously to better understand the role of disclosure. 
Genital Warts and Genital Herpes Disclosure 
Psychosocial Impact 
 The psychosocial impact of these STIs has been hotly contested.  Qualitative 
studies have suggested that acquiring genital herpes or genital warts has a profound 
impact on self-conceptualization (Hammarlund, Lundgren, & Nyström, 2007; Melville et 
al., 2003; Newton & McCabe, 2008b; Perrin et al., 2006; Taylor, Keller, & Egan, 1997), 
which requires the individual to come to terms with their diagnosis and preexisting 
prejudices concerning the types of individuals who obtain STIs.  One gentleman 
remarked, "Now they stigmatize me as I once stigmatized them" (Hammarlund et al., 
2007).  The process of placing oneself in the category of “individuals with a sexually 
transmitted infection” and melding that stereotype with existing thoughts about oneself is 
challenging (Perrin et al., 2006).  Many have adopted views that they were now dirty, 
undesirable, stigmatized, and less attractive (Melville et al., 2003).  The process of 
blending this new information was easier for individuals who did not hold strong 
prejudices or stereotypes regarding individuals who acquire STIs prior to their diagnosis 
(Hammarlund et al., 2007).  However, among individuals who held strong preconceptions 
this process took longer and the psychosocial impact of the diagnosis was stronger (Mark, 
Gilbert, & Nanda, 2009).  Advice from individuals who have genital warts for a year to 
those newly diagnosed included both the message to maintain a balanced view of genital 
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warts.  As part of the balanced view, individuals’ advice specifically mentioned that 
adjustment gets better over time (Taylor et al., 1997). 
Results from quantitative studies also support the theory that adjustment to a 
genital herpes diagnosis improves over time.  Individuals report the highest levels of 
psychosocial distress immediately following a diagnosis (Handsfield, Warren, Werner, & 
Phillips, 2007; Mark et al., 2009; Richards et al., 2007). The psychosocial trauma 
occurred for most individuals even if they did not have any physical symptoms of the STI 
(Richards et al., 2007; Rosenthal et al., 2006).  However, cohort studies have suggested 
that psychosocial disruptions were not long lasting, especially if participants were 
diagnosed through serologic testing for HSV2 (Richards et al., 2007; Rosenthal et al., 
2006).  The majority of studies tracking individuals with genital herpes found little 
overall increased psychosocial morbidity at three- and six-month follow ups, despite a 
peak at two-week and one-month measurements (Miyai et al., 2004).  The initial spike in 
psychosocial distress after a diagnosis was similar among those who have experienced 
genital warts for a longer period of time as well (Scrivener, Green, Hetherton, & Brook, 
2008). 
Although improvement in psychosocial well-being is demonstrated across time 
consistently for the majority of individuals, individuals who experience external physical 
symptoms of the disease experience lower levels of quality of life. Individuals with 
external genital warts reported lower levels of quality of life than those who experience 
normal Pap smears or abnormal Pap smears that have not been confirmed with biopsy 
(Pirotta et al., 2009).  However, individuals with genital warts reported lower levels of 
quality of life than those with a biopsy confirmation on more global measures of well-
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being, despite having a medically less serious condition.  Similarly, individuals who were 
diagnosed for HSV2 serologically without previous experience with symptoms displayed 
lower levels of prolonged distress than individuals with a history of herpes symptoms 
(Mark et al., 2009; Miyai et al., 2004; Rosenthal et al., 2006; Smith et al., 2000).  
Suppressive medication used with symptomatic herpes patients had a treatment/time 
interaction however, suggesting that suppressive treatment by reducing recurrences aided 
in increasing quality of life over time (Handsfield et al., 2007). 
Though global measures of psychosocial well-being tend to suggest gradual 
coping with a genital herpes or genital warts diagnosis, disease-specific measures tend to 
suggest a prolonged period of increased psychosocial distress.  Measures of general 
anxiety, depression, isolation, fear, and sadness have tended to show little to no 
difference from baseline among those newly diagnosed at three-month follow up (Miyai 
et al., 2004; Richards et al., 2007; Rosenthal et al., 2006).  However, measures specific to 
herpes-related quality of life indicate a different pattern.  Herpes-related quality of life 
measures show elevated distress that is disease specific regarding transmission, 
disclosure, and relationships (Mark et al., 2009; Newton & McCabe, 2008a; Richards et 
al., 2007; Rosenthal et al., 2006).  The Herpes Related Quality of Life scale (Doward et 
al., 1998) has elicited frequent endorsements of statements regarding the negative impact 
herpes plays in quality of life.  Disease-specific anxiety, depression, and quality of life 
have also been substantiated in the qualitative literature.  When asked about how the STI 
has impacted life, the majority of participants have reported ways that herpes or genital 
warts have negatively impacted their life or relationships (Melville et al., 2003; Newton 
& McCabe, 2008a).  However, many of these individuals also suggested that their overall 
17 
 
health was good and would not be categorized as clinically depressed or anxious.  The 
distinction between overall health and sexual health indicates that low risk STIs impact 
psychosocial well-being but not overall mental health or sociability.  
However, age may play a role in adjustment.  Studies that examine younger 
populations tend to report higher levels of distress than older populations.  Mark et al. 
(2008) found increased levels of psychosocial distress among individuals aged 18-39 
years who tested positive for HSV2 without herpes symptoms even at the three-month 
follow-up.  The individuals who tested positive reported lower levels of well-being on the 
General Health Questionnaire from baseline despite having no history of symptoms 
associated with genital herpes.  Conversely, Richards and colleagues (2007) found that 
older populations reported lower levels of psychosocial distress.   The median age of 
asymptomatic HSV2 diagnosis was 46 years old, and this population demonstrated lower 
levels of herpes related stress.  The psychosocial distress disparity is unlikely due to age 
alone, but rather how established one’s romantic relationship is.  Among younger 
populations, romantic relationships tend to be less stable and starting new relationships 
could be the source of the additional distress, whereas Richards et al. (2007) reported 
63% of the individuals were either married or living with a long term partner in their 
sample. 
Disclosure 
Disclosure sometimes occurs with non-romantic or non-sexual partners. 
Disclosure outside of romantic relationships is often encouraged in order to obtain social 
support, but is not given as much emphasis as disclosure within a relationship.  Women 
tend to disclose to friends and family more in order to seek social support (Barnack-
18 
 
Tavlaris, Reddy, & Ports, 2011; Dibble & Swanson, 2000; Perrin et al., 2006; Richards et 
al., 2007; Taylor et al., 1997).  Coping through seeking social support from family and 
friends is not utilized among men as much as it is among women.  Additionally, younger 
women who rely on parents for treatment and those with more serious complications 
might have been more likely to tell family members (Gilbert & Omisore, 2009; Pirotta et 
al., 2009).  Unlike individuals who disclose their HIV status to non-romantic others, this 
disclosure does not tend to affect the relationship between the parties as the nature of 
genital herpes or warts does not typically come into play in the relationship dynamics. 
Initiating new relationships can be anxiety-inducing for individuals with genital 
herpes (Mindel, 1993).  Patrick et al. (2004) reported the most frequently selected 
concern from a list of questions about a recent herpes diagnosis was: “Is this the end of 
my love/sex life?”.  Fifty-three percent of participants checked this option as one of their 
top three concerns.  Telling one’s partner about having herpes was most frequently the 
source of distress experienced after a herpes diagnosis (Lee & Craft, 2002; Mindel, 1993; 
Newton & McCabe, 2008b).  Zacharioudakis   (1993, p. 115) claimed that disclosure is 
“the single most stressful and anxiety/depression inducing issue confronting patients.”  
VanderPlate and Aral (1997) indicated the source of this stress is because disclosure is 
the time when one must face the social realities of the disease and confront their own 
fears concerning it.  Ethical and legal morays require one to tell a potential partner they 
could be at risk of acquiring the infection, however that puts the individual with herpes in 
a position to be rejected.  The fear of rejection is one of the most frequently cited 
negatives associated with having genital herpes (Lee & Craft, 2002; Melville et al., 2003; 
Mindel, 1993).  Despite this overwhelming and fairly universal fear, no study has 
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systematically explored whether or not disclosure results in rejection in a U.S. 
population. 
Disclosure to a romantic partner or potential sexual partner has been the primary 
focus in the disclosure literature.  In general, relationship characteristics tend to play a 
large role in the decision to disclose having genital herpes or genital warts.  Disclosure is 
more likely to occur in long term, close romantic relationships and least likely to occur 
with casual partners (Green et al., 2003; Newton & McCabe, 2008a; Scrivener et al., 
2008).  Additionally, individuals identified with symptomatic infection were more likely 
to tell an existing partner if the diagnosis occurred within the time of the relationship 
(Patrick et al., 2004).  The transition to a more serious relationship, such as moving in 
together or an engagement, can also prompt disclosure (Green et al., 2003).   
Fear of rejection plays a large role in the decision to disclose (Gilbert & Omisore, 
2009; Green et al., 2003; Melville et al., 2003).  In counseling sessions, Shepherd (2010) 
found that disclosure was associated with thoughts of rejection. In an analysis of herpes 
support chat room conversations, the majority of questions were about how to tell a 
partner and which partners were most important to disclose to (Gilbert & Omisore, 2009).  
Many individuals report not disclosing because they do not believe that their partner 
would take the news well or would end the relationship as a result.  Green and colleagues 
(2003) reported 32% of individuals did not disclose to their partner because of the 
potential for a negative reaction and 22% of the sample indicated non-disclosure was due 
to the inability to predict partner reaction and therefore disclosure was too risky.  
Disclosure is more likely to occur if the individual expects a more positive reaction from 
their partner (Green et al., 2003; Keller, von Sadovszky, Pankratz, & Hermsen, 2000).  
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Those who cannot ascertain a partner’s likely reaction are less willing to disclose (Green 
et al., 2003), and those who expect rejection and lack of support avoid disclosure 
(Newton & McCabe, 2008b; Scrivener et al., 2008). 
In assessing emotional responses to asymptomatic HSV-2 positive test results, 
Melville and colleagues (2003) found fear of disclosure was a large source of 
psychosocial morbidity.  Of their sample 45.8% reported a fear of telling a current 
partner, 16.7% reported a  fear of telling past partners, and 50% reported a fear of telling 
future partners as a source of distress as a result of their diagnosis.  These numbers may 
have underrepresented the fear of disclosure, as individuals with asymptomatic genital 
herpes diagnoses typically report less disclosure.  Several theories as to why this occurs 
have been posited.  Evidence suggests that experiencing symptoms of a genital herpes 
outbreak can prompt disclosure (Green et al., 2003).    
 The timing of disclosure to romantic partners has also been examined.  
Recommendations are to disclose prior to sexual intimacy in order to reduce the risk of 
transmission.  For infections like genital herpes and genital warts that are spread through 
skin-to-skin contact, this would ideally occur before any intimate touching in the genital 
region (American Social Health Association, 2012).  However, several studies have 
indicated that the onset of sexual intercourse is more poignant for disclosure.  
Additionally, many individuals report disclosing after engaging in sexual intercourse with 
a partner.  Scrivener et al. (2008) found that 69% of individuals who disclosed having 
genital warts did so after having engaged in sexual intercourse.  Additionally, Keller and 
colleagues (2000) found that 31% of individuals disclosed having genital warts after 
engaging in sexual intercourse. Among women who acquired genital herpes from a 
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partner, 46% reported that disclosure occurred after sexual initiation (Wald et al., 2006).  
Green and colleagues (2003) found that the pattern of sexual intercourse prior to 
disclosure could last for a significant period of time.  Even in times when disclosure does 
occur, it does not occur in a way most beneficial for behavior change. 
 Low levels of disclosure despite recommendations have led researchers to explore 
reasons for disclosure and non-disclosure.  Among those who disclose, the themes of 
honesty and partner’s right to know were most common (Keller et al., 2000; Newton & 
McCabe, 2008b; Scrivener et al., 2008).  Feeling that a partner had the right to know 
encompassed one’s moral and legal obligation, including the notion of informed consent 
to sex.  Desire to protect one’s partner was expressed as a reason for disclosure, but 
Hammarlund, Lungren, and Nystrom (2007) suggested that fear of transmission is less 
strong than the fear to avoid rejection.  Some of the most common reasons for non-
disclosure include lack of initiation of sexual intercourse (Keller et al., 2000), fear of 
rejection (Green et al., 2003; Hammarlund et al., 2007; Mark et al., 2009; Melville et al., 
2003; Newton & McCabe, 2008b; Scrivener et al., 2008; Shepherd, 2010), 
embarrassment (Keller et al., 2000; Scrivener et al., 2008), casual partner (Green et al., 
2003; Scrivener et al., 2008), and using condoms (Green et al., 2003; Scrivener et al., 
2008) among other less prominent reasons.  Interestingly, regardless of the decision to 
disclose or not disclose, the majority of individuals reported feeling “fine” or “good” 
about their decision (Keller et al., 2000). 
 Several studies have implicated that there are benefits to disclosure.  Those who 
disclose have reported lower levels of anxiety than those who do not (Newton & 
McCabe, 2008a; Scrivener et al., 2008).  It is not clear if lower levels of anxiety lead to 
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non-disclosure or whether non-disclosure leads to higher levels of anxiety.  However, it is 
likely that withholding the information from someone can add to any preexisting anxiety, 
as the fear that they could find out is present.  Disclosure was associated with low levels 
of regret (Keller et al., 2000).  Regret was higher among non-disclosers (Scrivener et al., 
2008) and individuals who delayed disclosure until after initiation of sexual intercourse 
(Keller et al., 2000). This low level of negative reactions from partners could be due to 
the relationship between expectations and disclosure, whereas those who expect less 
negative responses disclose at higher rates.  Scrivener et al. (2008) found that support 
from one’s partner actually increased over time for the majority of individuals who 
disclosed, though they do mention some negative effects to the relationship.   
Weaknesses of Disclosure in Herpes Prevention 
Only one study conducted has suggested an association between disclosure and 
transmission delay.  Wald and colleagues (2006) found relationships in which disclosure 
was associated with a longer time (270 vs. 60 days) until HSV-2 acquisition.  However, 
this relationship did not exist for individuals with genital HSV-1 diagnosis.  Several 
limitations exist with these findings.  First, this retrospective study only examined 
disclosure among symptomatic individuals who sought STI services.  Additionally, the 
sample of individuals who experienced a disclosure was very small (n = 22) and were 
overwhelmingly female.  Finally, disclosure of genital herpes status could have occurred 
prior to or after sex.  Because disclosure could occur either before or after sex, one must 
question exactly by what mechanism this was protective.  Merely knowing that you could 
have been exposed after the fact does not provide any additional protection during the sex 
act.  Further research is necessary to understand the association between disclosure and 
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genital herpes acquisition.  As of now, the recommendation exists more due to moral and 
ethical mores rather than scientific evidence as an effective risk reduction strategy. 
Methodological Considerations 
 To address the specific aims of 1) identifying individual and relationship 
characteristics that are associated with genital herpes disclosure in a sample of 
individuals with genital herpes and 2) understanding how past partner reactions to a 
genital herpes self-disclosure are related to future intentions to disclose, several 
methodological considerations are discussed.  
Sample 
 The primary challenge when conducting genital herpes research is identifying and 
obtaining the population of interest.  Individuals with genital herpes are a highly 
stigmatized, hard to reach population (Breitkopf, 2004).  A comprehensive sampling 
frame for individuals with genital herpes does not exist, therefore non-random sampling 
methods are appropriate (Neuman, 2006).  Due to the concealability of genital herpes and 
the stigma associated with the disease, it is hard to identify individuals with genital 
herpes (Breitkopf, 2004).  Despite the prevalence of genital herpes in the U.S., few 
individuals who have HSV are aware of it.  According to the most recent NHANES data, 
approximately 80% of individuals who tested positive for HSV-2 did not report having 
genital herpes (Xu et al., 2010).  This considerably reduced the target sample size, 
because individuals must be aware they have genital herpes and had to have an 
experience in which they needed to disclose having HSV.   
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Design 
Past studies examining disclosure of genital herpes status to a potential or past 
romantic partner primarily used qualitative methods to collect information (Green et al., 
2003; Melville et al., 2003; Newton & McCabe, 2008b).  This study builds on previous 
qualitative findings to understand associations between concepts of disclosure, partner’s 
reactions, rejection, and future intentions to disclosure.  To my knowledge a quantitative 
approach has yet to be used to explore genital herpes disclosure with specific regard to 
perceptions of partners’ reactions and rejection.    Therefore, this study will be the first to 
apply inferential statistics to associations noted in the qualitative literature to understand 
the statistical relationships between factors identified in the qualitative literature as being 
important to the disclosure experience. 
 Beyond the ability to estimate prevalence and associations, there are several other 
benefits to utilizing a quantitative approach.  A quantitative approach, and more 
specifically a survey method, allows researchers to collect a large amount of data from a 
variety of participants in a smaller time frame (Neuman, 2006).  A greater level of 
anonymity also is established through surveys over face-to-face interviewing (Neuman, 
2006).  Rather than having to identify as someone who has genital herpes to a researcher 
in person, an individual can fill out the survey privately without additional people 
knowing about their condition.  Anonymity may also increase the reliability and validity 
of findings, as individuals may be more inclined to answer truthfully to sensitive material 
and less inclined to provide a socially acceptable answer (Neuman, 2006).   
 The quantitative approach also has its drawbacks.   One of the primary drawbacks 
discussed above is the need for a sufficiently large sample to adequately perform 
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inferential statistics.  A sample must be sufficiently large to provide enough power to 
correctly reject the null hypothesis (Stevens, 2007).  With a sample that is hard to obtain, 
this reduces the feasibility of the study.  Without a sufficiently large sample, this 
approach loses many of its benefits, such as the ability to conduct inferential statistics 
(Pedhazur, 1997).   
 This study is largely descriptive in nature.  The majority of the analyses are basic 
associations using chi-square statistics.  The statistical procedure requiring the largest 
sample size for adequate power included in this proposal is logistic regression.  Power 
analyses for logistic regression suggest that required sample size is dependent on both the 
number of predictors in the regression equation and the expected effect size of the 
predictor of interest (Pampel, 2000).  Factors significant in bivariate analyses were 
included in the regression model.  The general rule of thumb for sample size calculation 
suggests 10 cases for each variable in the logistic regression model (Peduzzi, Concato, 
Kemper, Holford, & Feinstein, 1996), however more recent simulation studies suggest 
that this rule can be relaxed (Vittinghoff & McCulloch, 2007).  As four variables were 
significant at the bivariate level, a minimum sample size of 40 was necessary to conduct a 
logistic regression.  This expectation was met. 
 Data Collection 
Previous genital herpes studies have predominantly recruited participants through 
three venues: STI clinics, HSV testing trials, and herpes support groups.  Individuals 
recruited through clinics generally are seeking a diagnosis or treatment for genital herpes 
symptoms.   Individuals with symptomatic genital herpes have reported lower quality of 
life and worse psychosocial adjustment to having genital herpes as compared to 
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individuals with asymptomatic HSV (Keller, Jadack, & Mims, 1991; Rosenthal et al., 
2006; Smith et al., 2000).  Individuals recruited through this venue typically receive an 
initial diagnosis of genital herpes.  This sampling strategy has dominated literature that 
looks prospectively at psychosocial implications of a genital herpes diagnosis. However, 
this recruitment strategy is limiting in several ways.  Individuals with genital herpes 
generally experience the highest amounts of anxiety and stress right after their initial 
diagnosis (Mark et al., 2009).  Studies have suggested the acute, negative psychosocial 
distress tends to decrease over time (Wald & Ashley-Morrow, 2002).  Also, these 
individuals have not had experience with forming new relationships with knowledge 
about having genital herpes.  Therefore, their disclosure experiences with a sexual partner 
are predominantly limited to the existing relationship they are currently in upon 
diagnosis.  Findings suggest that disclosure is highest in this context, as genital herpes 
has a very short incubation window (2-20 days) and the infection most likely came from 
their current partner prompting disclosure (Patrick et al., 2004).   
Though HSV testing trials typically operate through clinics (ClinicalTrials.gov, 
2012), these individuals are characteristically different than individuals who are 
diagnosed after seeking treatment for symptoms of genital discomfort.  To be included in 
these studies, inclusion criteria require that the individual does not have a previous 
diagnosis of genital herpes or previous genital herpes symptoms.  During the study, these 
individuals are primarily diagnosed through HSV anti-body test.  It is only after test 
results that the majority of individuals are aware of their herpes status.  As mentioned 
above, symptomatic individuals tend to display the highest levels of distress.  
Additionally, enrollment in these trials is accompanied by higher levels of counseling 
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post diagnosis than is traditionally experienced in other medical settings (Wald & 
Ashley-Morrow, 2002).    
Though support groups offer a venue for gathering a number of individuals with 
genital herpes at one time, evidence suggests that individuals attending these support 
groups cope differently than other individuals with genital herpes.  These individuals tend 
to report more psychosocial consequences of having genital herpes.  Therefore, in 
understanding stigma and disclosure, these individuals might not be indicative of the 
larger population with genital herpes (Breitkopf, 2004). 
One study of genital herpes disclosure employed an online convenience sample of 
individuals with genital herpes and human papillomavirus.  Newton and McCabe (2008a) 
hosted a link to their online questionnaire on sexual health websites, support groups, 
online communities specializing in herpes and HPV, and general health websites.  One of 
the limitations highlighted was that individuals recruited through these sites specifically 
may have a more negative experience with having an STI than other individuals with 
these STIs (Newton & McCabe, 2008a).  To address and build upon this limitation, this 
study recruited participants from a variety of online venues.  In addition to herpes-
specific and STI-specific online venues, broader online communities were utilized for 
recruitment.  This includes social networking sites (SNS) like Facebook and Twitter, 
which may cull a different segment of the population of interest.   
The initial sites that served as recruitment venues were Twitter and Facebook.  
For Twitter and Facebook, the link to the questionnaire was posted on the PI’s personal 
account several times between February and April 2014.  In order to promote the link’s 
reach, I personally asked several close friends to post the ad on their Facebook page with 
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a message.  Several others “liked”, “shared”, and “retweeted” the link on their own 
accord.  A snowball sample of individuals was reached through the “share” option on 
Facebook and the “retweet” option on Twitter, as each new share or retweet advanced the 
survey through different individuals’ streams.  According to the website muckrack.com, 
that examines content reach on social media sites, the survey link was shared on 
Facebook 173 times and retweeted on Twitter 8 times. 
The initial pool of herpes specific dating sites contacted were: hwerks.com, 
positivesingles.com, hmates.com, mpwh.net, afterh.com, STDFriends.com, H-Date.com, 
and loveHstyle.com.  Only one site returned my email request, denying me the 
opportunity to post my survey on their site, citing site privacy stipulations as the reason 
for denial.  No other site returned my email. Though initially proposed as a potential 
recruitment venue, this was not successful. 
However, the survey was distributed through a variety of other electronic 
channels during the data collection period.  First, several personal contacts sent out the 
survey link over email listservs including: HEDIR for health educators, SSSStalk which 
is the listserv for the Society for the Scientific Study of Sexuality, Sexnet, and USF Talk 
which is an internal school listserv with 800 participants.  Instructors for the spring 2014 
undergraduate Sex, Health, and Decision Making class also sent out the link to the survey 
to their students.  Dr. Justin Lehmiller, a prominent sexuality researcher who maintains a 
research blog and website also posted the survey to his webpage (www.lehmiller.com) 
and blogged about the study after hearing about it through SSSStalk.  The survey link 
was also posted to Reddit in three separate Reddit foums: /surveyresearch, /samplesize, 
and /gradschool.  Additionally, ASHA posted the survey to their research opportunities 
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forum. According to responses, the survey also was available through linkedin, 
askisadora.com, and positivesingles.com, thought these were not sites identified or 
approached by the PI. 
Web-based surveys are cost effective and provide a high level of anonymity for 
the participant (Neuman, 2006).  Using this approach allowed both symptomatic and 
asymptomatic individuals to access allowing for a larger swath of individuals with genital 
herpes.  Using a web-based surveys also allowed for examining the quality of the data 
continuously throughout the data collection process through summary reports. This 
allowed for minor changes to the survey instrument to improve data collection problem 
while it was still occurring.  This is as opposed to paper and pencil surveys in which the 
quality of the data collected is normally assessed at data entry (Neuman, 2006).  Online 
data collection also eliminated the need for manual data entry into an electronic file 
suitable for analysis.  Not only did this save time, but it can reduce errors associated with 
miscoding and data entry errors (Neuman, 2006).  Another feature of web-based software 
tools that increases data quality is the ability to prompt the participant regarding 
questions that must be answered, that they skipped a question, or include built in skip 
patterns that increase the quality of the data collected by decreasing user error (Dillman, 
Tortora, & Bowker, 1999).   
Drawbacks exist when utilizing a web-based surveying technique.  The largest 
limitation of online surveys is that it is not possible to conclusively identify who is filling 
out the survey without collecting specific identifying information (Neuman, 2006).  
Anyone who can access the survey becomes a participant, whether he or she is part of the 
intended population or not.  To reduce the threat of sample validity, several methods were 
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adopted.  A screener was added to the questionnaire so that participants could not 
determine which combination of questions would gain entry into the full survey 
instrument.  Incentives for participation were also kept low to discourage participation 
from individuals not in the intended population.  Finally, the data collected were 
rigorously examined for implausible or unlikely response patterns to increase the validity 
of the data.   
This study employed a screener prior to gain access to the full study.  The study 
was advertised as a study about sexual communication in relationships.  Only individuals 
who indicated that they were 1) 18+ and 2) had genital herpes gained access to the full 
study questionnaire.  Additionally, the assumption of the ability to read English underlies 
the inclusion criteria, as the web-based module was only in English.  As there were 
distinct requirements to gain entry, the chances that someone would haphazardly gain 
access to the survey were reduced.  Survey results were eliminated if the screener was 
accessed by the same IP address more than three times with varying responses.  Cases 
were also eliminated based on atypical response patterns after examining each on a case 
by case basis.  These cases were eliminated on the assumption that they were bogus 
cases. 
Measures 
Stigma.  One must look broadly to measure genital herpes stigma.  No herpes 
stigma scale exists (Breitkopf, 2004).  Closely related, the Herpes Attitude Scale 
measures perceptions of genital herpes (Bruce & McLaughlin, 1986; Fisher, Davis, 
Yarber, & Davis, 2011).  This scale measures attitudes about genital herpes in ways more 
appropriately suited to a population who has not had a genital herpes diagnosis.  
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However, there are several other stigma scales that apply to sexually transmitted 
infections broadly and other more STI disease-specific scales that have been validated 
(Fisher et al., 2011).   
The Berger HIV Stigma scale consists of four factors including personalized 
stigma, disclosure concerns, negative self-image, and concern with public attitude with 
HIV (Berger, Ferrans, & Lashley, 2001).  Exhibiting high levels of internal consistency 
reliability and construct validity as evidenced by correlations with commonly used 
mental health measures, this 40 question scale includes many items that can be easily 
adapted to measure herpes-related stigma simply by changing HIV to herpes.  However, 
the scale is lengthy and time consuming with several items that do not apply to the genital 
herpes context.  These items typically describe the perceptions or impacts of HIV outside 
of a sexual relationship context.  Whereas HIV can broadly affect one’s overall health 
and thus broader social interactions, herpes is more confined to relationships of a sexual 
nature (Breitkopf, 2004).  Therefore, items such as “Easier to avoid friendships than 
worry about telling” do not apply to the genital herpes context. 
Wright and colleagues (2007) tested an abbreviated version of the HIV Stigma 
Scale developed by Berger and colleagues.  The revised 10 item scale captured all four 
dimensions of stigma measured in the original extended scale while maintaining high 
internal consistency reliability with each subscale scoring a Cronbach’s alpha level of.70 
or greater and demonstrating high correlations with the original subscales. Most of the 
items tested for the abbreviated HIV Stigma Scale were easily adapted to measure herpes 
stigma simply by changing “HIV” to “herpes” in the item.  However, two items did not 
apply as readily to the herpes context: “I have stopped socializing with some people 
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because of their reactions of my having HIV” and “I have lost friends by telling them I 
have HIV.”  Both items are part of the Personalized Stigma subscale.   
The HIV scale developed by Berger and colleagues (2001) served as the initial 
pool of items for a herpes specific stigma scale.  As the thrust of the current research is to 
understand stigma, disclosure, and rejection, additional items were taken from the 
Disclosure and Public Attitudes subscales.  Wright and colleagues (2007) also 
demonstrated that the 40 item scale maintained its psychometric properties when reduced.  
Therefore, not all items were used in order to moderate survey length.  As such a 12 item 
abbreviate version of these scales was used to measure stigma perceptions.  The scale 
demonstrated high internal consistency reliability (α= .906).  
Rejection.  No scale currently measures rejection and more specifically, sexual 
rejection.  Scales that deal with rejection in the psychological literature refer to coping 
with rejection and not perceptions of rejection themselves.  Therefore, the assessment of 
sexual rejection was determined through elements defining a sexual rejection in the 
qualitative literature.  A new scale to measure rejection was not developed.  Instead, a list 
of potential partner reactions taken from the qualitative literature acted as an index of 
common partner reactions to disclosure and perceptions of rejection. 
Pilot Testing 
 As this is a hard to reach sample, quantitative pilot testing of the measures was 
not feasible prior to questionnaire launch.  Instead, the instrument was assessed for 
validity and sensitivity using a five phase pretesting process.  First, the questionnaire was 
reviewed by experts in the areas of measurement, human sexuality, sexually transmitted 
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infections, and disclosure.  The doctoral committee served as the expert review board.  
After integrating suggested changes, phase two, cognitive interviewing, began.   
Cognitive interviews were conducted according to the principles outlined by 
Willis (1999).  Cognitive interviewing is a tool that can be used to identify sources of 
response error in a questionnaire.  Cognitive interviews explore the cognitive processes 
used by respondents to answer survey items.  Interviews are conducted with volunteer 
participants who have characteristics of interest to the questionnaire.  The theoretical 
cognitive underpinnings of cognitive interviewing include: 
1) Comprehension of the Question:  This aspect of cognitive interviewing attempts 
to understand the interpretation of an item’s intent and meaning from the 
perspective of the survey respondent.  If a survey respondent does not interpret an 
item in a way intended by the researcher, the item is subject to clarification and 
retooling for clarity.  Indentifying incongruencies between the researcher’s intent 
behind the question and the interpretation of the respondents’ interpretation serves 
as a validity check. 
2) Retrieval from Memory of Relevant Information:  This aspect of the cognitive 
interview attempts to gauge how difficult an item is to answer.  This includes an 
understanding of what information is necessary to answer the item accurately and 
the strategies employed by the respondent to recall the information of interest.  If 
an individual struggles to employ an efficient and accurate recall strategy, the 
question might pose problems. 
3) Decision Processes:    The decision process includes the concepts of motivation 
and sensitivity/social desirability.  Through this component of the cognitive 
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interview, the researcher attempts to grasp if the respondent devotes sufficient 
mental effort to answer the question accurately, as well as identify any desire to 
answer differently from the truth.  If an individual feels drawn to respond in a 
more socially desirable way, this might be an opportunity to reframe the question 
to appear less judgmental thereby increasing the validity of responses.  As social 
desirability is a prominent concern for this line of research, particular attention 
was paid to reactions of cognitive interviewees in this realm. 
4) Response Processes:  This final category ascertains if the answer or conclusion an 
interviewee came to is able to map onto one of the response categories provided. 
This can identify insufficient response options for the item. 
Individuals with genital herpes known to the investigator personally served as 
interviewees for the cognitive interviews.  Interviews were conducted over the phone and 
internet in real time as the candidates do not live locally.  Conversations were audio 
recorded and notes were taken during the interview.   Participants were asked to read 
questions aloud as they clicked through the electronic survey and describe their thought 
process on answering each question.  Additionally follow-up questions were asked as 
appropriate.  Question wording and sensitivity were emphasized with participants and 
suggestions for question improvement were solicited. 
Peer reviews occurred during the 3rd pretesting phase.  Eight peers (graduate 
students, faculty, and research staff) reviewed the survey instrument for wording and 
accuracy.  Between each peer review, changes were made to the survey instrument until 
there were no additional critiques.  An iterative process of review and updating continued 
until no substantive changes were recommended by to consecutive peer reviewers.  Next, 
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in phase 4, the survey was reviewed for flow (including appropriately functioning skip 
patterns) and response option availability using a role play scenario of a fictional 
character provided by the PI.   
Finally, in phase 5 of pretesting, two additional cognitive interviews were 
conducted with individuals with genital herpes in order to review changes made to the 
questionnaire in the previous phases.  One of the interviewees was a new participant, 
serving as an additional new set of eyes and perspective on the questionnaire.  The 
second participated in the first round of cognitive interviews and was specifically probed 
about changes made since the first cognitive interview. 
Primary Gaps in the Existing Literature 
Although many studies examine the psychosocial effects of genital herpes, less is 
known about the patterns of disclosure and the role that perceived partner reaction plays 
in the disclosure process, including future intentions to disclose.  Only qualitative studies 
have discussed the results of disclosure in the U.S., and data are scattered throughout 
studies examining the psychosocial ramifications of having genital herpes.   
The most comprehensive study of disclosure and perceptions of rejection used a 
mixed methods approach (Green et al., 2003).  This study was conducted through a STI 
clinic in London, England and examined individual and relationship characteristics 
associated with disclosure, such as seriousness of the relationship, recency of 
relationship, and gender.  Additionally, it was the first study in the herpes literature to 
quantitatively assess an individual’s overall perception of his or her partner’s reaction as 
either positive or negative.  However, this study did not however explore: 1) the range of 
responses a partner might have, 2) how this in turn affects perceptions of partner 
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response, and 3) subsequent perceptions of rejection, or 4) use a defined theoretical 
framework.  This study expands on the work of Green and colleagues by addressing these 
four identified gaps.   
Quantitative studies have yet to examine what characteristics of the individual 
and/or relationship that is associated with disclosure among individuals living with 
genital herpes in the U.S.  Notably studies have not focused on the role of rejection in 
disclosure, despite a heavy emphasis on this concept in the qualitative literature.  
Furthermore, the role of partner’s reaction on future intentions to disclosure has been 
explored to only a limited extent.  The impact of a partner’s reaction has on the intention 
to disclose in the future has yet to be explored using a quantitative approach.   This study 
builds on findings from qualitative literature domestically and quantitative literature from 
the international stage to understand disclosure further. 
Research Questions 
Specific Aim 1: Identify individual and relationship characteristics that are associated 
with genital herpes disclosure at last sex in sample of individuals with genital herpes. 
a. What is the prevalence of genital herpes disclosure at last sex among this 
sample? 
b. What individual-level characteristics including age, gender, race, 
symptomatic versus asymptomatic testing, stigma perceptions, sexual 
orientation, and time since diagnosis are associated with genital herpes 
disclosure? 
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c. What relationship characteristics including time in relationship, type of 
relationship, and sexual progression are associated with genital herpes 
disclosure? 
d. When in the sexual progression of a relationship do individuals disclose? 
e. Are expectations of a partner’s reaction associated with the decision to 
disclose? 
f. Which combination of individual and partner characteristics best predict 
disclosure? 
g. What are reported reasons for disclosure and non-disclosure? 
Specific Aim 2:  Understand how past partner reactions to a genital herpes self-disclosure 
are related to future intentions to disclose. 
a. What reactions are associated with future intentions to disclose? 
b. Is the overall assessment of a partner’s reaction associated with future 
intentions to disclose? 
c. Is the perception of rejection at last disclosure associated with future 
intentions to disclose?  
Significance 
Current counseling messages and disclosure recommendations are not 
substantiated by existing research.  Messages regarding disclosure fears and managing 
expectations of disclosure supported by the most prominent public health organization in 
the country are anecdotal and without scientific support.  CDC recommendations 
promoting disclosure also do not discus psychosocial repercussions or public health 
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benefits of this strategy.  This study explored perceptions of partner reactions to 
disclosure in order to better understand the nature of disclosure aftermath.   
The findings from this research may have numerous implications for health 
education messaging.  Findings can help shape health education programming regarding 
facilitating a successful disclosure.  Clinic-based interventions for coping with a genital 
herpes diagnosis will vary based on the extent to which fears of rejection match the 
realities of sexual denial as a result of disclosure.  If fears of rejection match intentions 
regarding sexual interaction held by those without a genital herpes diagnosis, then 
interventions must maintain the status quo of stressing the legal and ethical implications 
of disclosure.  However, if expectations of rejection do not match intentions of potential 
sexual partners, then interventions can evolve around the idea of matching expectations 
matching realities rather than fearing for the worst reaction to a disclosure.  
The present study is timely, as recommendations for asymptomatic testing are 
still evolving and asymptomatic testing rates are increasing.  This potentially means that 
many with newly diagnosed asymptomatic genital herpes face disclosure decisions.  This 
is important since the impact of the disease for these individuals completely lacks a 
personal physical element, leaving consequences of testing to be interpersonal. 
 This study is unique because it is the first study to examine partner’s reactions to 
a disclosure in a primarily U.S. sample using a quantitative approach.  Findings also 
provide the first estimates, known to date, of rejection perceptions.  
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Theoretical Approach 
Theoretical Conceptualization 
 Existing studies examining disclosure of genital warts or genital herpes to one’s 
partner are largely qualitative in nature, and without an a priori theoretical framework.  
From these qualitative studies, little formal theory development has occurred.  However, 
general groupings of barriers and facilitators of disclosure have been explored, and 
stigma is a recurrent theme (Bickford, Barton, & Mandalia, 2007; Cunningham, Tschann, 
Gurvey, Fortenberry, & Ellen, 2002; Melville et al., 2003; Newton & McCabe, 2008b; 
Perrin et al., 2006; Scrivener et al., 2008).   
Stigma Theory evolved from Goffman’s (1963) original work regarding the 
stigmatized “other”.   A stigma by nature indicates a devalued position or a spoiled 
identity (Goffman, 1963). Realizing that one has a condition that is stigmatized separates 
them from the rest of “normal” society.  Others distance themselves from the stigmatizing 
condition through stereotyping and separation.  Further conceptualization of stigma has 
been seen throughout the literature. 
Building on Goffman’s work, Link and Phelan (2001) conceptualized stigma as 
having five core elements.  Incorporating the core underpinnings of Goffman’s stigma 
premise, Link and Phelan also asserted that 1) stigma creates a divide between “us” and 
“them”.  The stigma concept also 2) incorporates the ability to recognize and identify 
human differences.  3) Stereotyping occurs in which a label associated with an 
undesirable condition.  Being associated with a stigmatizing condition incurs a 4) status 
loss and 5) discriminatory behavior.   
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The role of discrimination in the conceptualization of stigma has been challenged.  
In her reassessment of the conceptualization of stigma, Deacon (2006) suggested that 
discrimination is just one form of status loss rather than being inherent to the concept 
stigma itself.  Deacon viewed stigma in terms of Joffe’s conceptualization of stigmatized 
illnesses (Joffe, 1999), which includes “1) Illness is constructed as preventable or 
controllable; 2) ‘Immoral’ behaviors causing the illness are identified; 3) The behaviors 
are associated with ‘carriers’ of the illness in other groups, drawing on existing social 
constructions of ‘other’; 4) Certain people are thus blamed for their own infection; and 5) 
Status loss is projected onto the ‘other’, which may (or many not) result in disadvantage 
to them.” (Deacon, 2006, p. 421).  This especially applies in micro-levels of experiences 
of stigma, such as in interpersonal relationships.   
In Breitkopf’s application of Stigma Theory to genital herpes, a stigma is 
intensified if it is believed to be acquired as a result of one’s actions or is the 
responsibility of the one possessing the stigmatizing condition (Breitkopf, 2004).  
Individuals with genital herpes experience enhanced stigma due to their active role in 
acquiring the stigmatizing condition, ties with sexual activity specifically make the 
stigmatizing condition even more taboo.  Breitkopf also highlighted that STIs present a 
unique way to examine stigma, as the stigmatizing condition itself is not readily apparent 
(Breitkopf, 2004).  For instance, genital herpes can remain hidden from the public eye 
and symptoms of the virus only appear sporadically, if at all (Centers for Disease Control 
and Prevention, 2006).  Rather than simply coping with the stigma associated with genital 
herpes on a day to day basis, such as someone with a readily apparent stigmatizing 
condition (e.g., speech impairment), individuals with STIs have to manage and protect 
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information regarding their condition.  It therefore becomes a situation of discretionarily 
exposing themselves as a stigmatized other.   Due to the concealability of having an STI, 
one is not automatically discredited, rather they are discreditable (Newton & McCabe, 
2005).  The process of disclosure is the process of revealing one’s stigmatized condition 
and potentially positioning oneself as an “other.”  Individuals with genital herpes often 
can maintain anonymity for a lifetime due to the regionalized nature of their infection and 
lack of need to tell non-romantic others. 
  Stigma Theory provides a natural underpinning to understanding disclosure 
reasoning among individuals with genital herpes.  Genital herpes alone, though a 
stigmatizing disease, does not come with all of the consequences of having a negatively 
viewed trait because it is a concealable condition.  It is not until one discloses their HSV 
status to others when they become at risk for being viewed negatively.  Therefore, if one 
does not disclose, s/he maintains their “normal” status.  However, it is noted that not 
everyone with a traditionally stigmatizing condition, such as a sexually transmitted 
infection, accepts the societal view of their condition (Breitkopf, 2004).  This theory 
suggests that individuals who internalize the negative stigmas associated with STIs, and 
more specifically genital herpes, will report lower levels of satisfaction and might be less 
likely to disclose their condition to potential partners. 
Prior Stigma Theory Applications 
 Stigma Theory has been used throughout the literature examining disclosure with 
STIs.  Cunningham and colleagues (2002) found that stigma internalization regarding 
sexual behavior was associated with a reduction of care seeking behaviors among young 
women.  Stigma internalization refers to accepting negative societal beliefs about a 
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condition as a perceived public truth. Women who anticipated negative reactions by 
medical personnel were least likely to disclose sexual behaviors.  Similarly, in interviews 
Cunningham and colleagues (2007) found a reluctance to disclose an STI diagnosis 
among adolescent females despite knowledge of the need to inform potentially infected 
partners of their diagnosis.  This reluctance was exhibited due to the psychosocial costs 
of disclosure.  What is interesting to note, is that the stigma associated with their 
conditions was transitory, as these women all were diagnosed with curable infections of 
either chlamydia and/or gonorrhea.  Therefore, informing partners had a clear physical 
benefit of treatment if infected.  However, unlike curable STIs, disclosing a genital 
herpes status is not transitory, as the virus cannot be cured (Centers for Disease Control 
and Prevention, 2010a).   
 Stigma internalization is an important concept.  Numerous scales exist to measure 
stigma.  Studies that have examined relative stigma of various diseases sometimes focus 
on six elements of a stigmatizing condition, including concealability, course, strain, 
aesthetic qualities, cause, and peril.  Studies using these criteria have found that STIs 
rank among the most stigmatized conditions (Jones et al., 1984; Patrick et al., 2004).   
Study Application 
 In application of the theory to the present research, the extent to which one 
identifies with the stigma associated with genital herpes may moderate disclosure and 
rejection perceptions.  Those who internalize higher levels of HSV stigma might be less 
likely to disclose to a partner or report worse expectations of partner reaction.  
Additionally, those who experience a rejection as a result of a genital herpes disclosure 
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might report higher levels of genital herpes stigma.  Both of these might affect future 
intentions to disclosure. 
Terms 
Definitions 
Sexually transmitted infection (STI): Belonging to a category of conditions that are 
commonly grouped together because they can be transmitted through sexual contact, also 
commonly referred to as sexually transmitted diseases (STDs). 
Genital herpes: Genital herpes refers to having herpes simplex virus infection (HSV) in 
the genital (vaginal, penile, or anal) region of the body. 
Disclosure: Disclosure is the process of telling someone about having a sexually 
transmitted infection. 
Partner notification: Partner notification is a larger umbrella term of strategies used to 
notify individuals about sexually transmitted infections, either among those potentially 
already exposed or those who might be at future risk. 
Genital warts:  Genital warts refers to low-risk human papillomavirus (HPV) infection in 
the genital (vaginal, penile, or anal) region of the body. 
Terminology Applications 
 Different organizations use the terms sexually transmitted infection (STI) and 
sexually transmitted disease (STD) to refer to the same group of conditions that are 
transmitted through sexual contact.  These terms are used interchangeably typically 
depending on author or organization preferences.  For this study, the term sexually 
transmitted infection is used throughout for consistency. 
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Associations between Individual and Relationship Characteristics and Genital 
Herpes Disclosure  
Abstract 
 
Disclosure is one strategy recommended for controlling the spread of genital 
herpes.  This study explores determinants of genital herpes disclosure with one’s most 
recent sexual partner using an online questionnaire (N=93).  The majority of participants 
(80.4%) disclosed.  Among non-disclosers, fear of a negative partner reaction was the 
primary reason for non-disclosure.  Age, relationship commitment, time in a relationship, 
and expectations of a partner’s reaction were significant predictors at the bivariate level.  
Reaction expectations and relationship commitment remained significant in logistic 
regression modeling. Findings indicate that future disclosure research should focus on 
relationship context and managing negative expectations to increase disclosure. 
 
Background 
 
 Genital herpes is one of the most common sexually transmitted infections (STIs) 
in the United States (Centers for Disease Control and Prevention, 2010a).  Genital herpes 
is a common, incurable skin infection caused by herpes simplex virus (HSV) types 1 and 
2 that is typically transmitted through skin-to-skin contact.  Symptoms of genital herpes 
range considerably but are most commonly recognized as painful, red sores in the 
anogenital region. 
National statistics examine HSV-2 seroprevelance to estimate the prevalence of 
genital herpes in the U.S.  Data from the National Health and Nutrition Examination 
45 
 
Survey (NHANES) suggest that the prevalence of genital herpes declined from 21% in 
the 1988-1994 cycle to 17% in the 1999-2004 cycle (Xu et al., 2006) and leveled off to 
16.2% in the 2005-2008 cycle (Xu et al., 2010).  However, HSV-2 seroprevalence as the 
indicator of population genital herpes underestimates the actual prevalence of genital 
HSV (Centers for Disease Control and Prevention, 2012b).  Though presence of HSV-2 
antibodies almost always indicate genital infection (Centers for Disease Control and 
Prevention, 2010a), HSV-1, historically associated with oral herpes, is a growing 
contributor to genital herpes cases (Lafferty et al., 2000; C. M. Roberts et al., 2003; 
Wald, 2006).  The Centers for Disease Control and Prevention (2006) suggests that up to 
50% of genital herpes cases could be due to HSV-1.  As such, conservative estimates 
report that more than one in six Americans have genital herpes based on HSV-2 
seroprevalence.  
Despite the common nature of genital herpes, many individuals with the infection 
are not aware they carry the virus (Centers for Disease Control and Prevention, 2010a; 
Xu et al., 2010).  Studies suggest approximately 80% of individuals with genital herpes 
have not received a clinical diagnosis, and as many individuals are asymptomatic or 
display low level symptomology (Xu et al., 2010). Individuals who are aware of having 
herpes face a variety of physical, emotional, and social health issues.  From a physical 
health standpoint, genital herpes is a minor medical issue, a transient skin rash with few, 
if any, physical consequences (Centers for Disease Control and Prevention, 2010a).  The 
social and emotional repercussions of contracting an incurable and highly stigmatized 
STI, however, can be considerable (Green, 2004; Mark et al., 2009; Melville et al., 2003; 
Newton & McCabe, 2008a).  
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Individuals with genital herpes often report that the social repercussions of herpes 
are the most worrisome aspect of genital herpes infection (Barnack-Tavlaris et al., 2011; 
Bickford et al., 2007; Melville et al., 2003; Swanson & Chenitz, 1993).  Much of the 
psychosocial distress is derived from the stigma attached to genital herpes.  Goffman 
(1963) first conceptualized stigma as being associated with a devalued position in which 
someone is separated from “normal” society and relegated to the position of the “other”.  
More recently, Link and Phelan (2001) referenced status loss in their conceptualization of 
stigma.  When applying stigma theory to genital herpes disclosure, Breitkopf (2004) 
noted that a stigma is intensified if the medical condition is considered preventable.  As 
the preventable action or behavior in the case of genital herpes is sexual activity, an 
additional layer of stigma is applied due to the taboo nature of sexuality in American 
society (Inhorn, 1986).  These factors, as well as negative and sensational media 
attention, place genital herpes among the most stigmatized health conditions (Breitkopf, 
2004; Posner, 2000; R. E. L. Roberts, 1997).   
Despite possessing a highly stigmatized, incurable, and transmissible virus, 
someone with genital herpes can protect themselves from the status loss associated with 
genital herpes through concealing their stigmatizing condition.  Rather than coping with 
the stigma associated with genital herpes on a day-to-day basis, such as someone with a 
readily apparent stigmatizing condition (e.g., speech impairment), individuals with STIs 
have to manage and protect information regarding their condition (Lee & Craft, 2002).  
People with genital herpes can maintain anonymity for a lifetime because of the 
regionalized nature of their infection.  Due to the concealability of having an STI one is 
not automatically discredited; instead, they are discreditable (Newton & McCabe, 2005).  
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It therefore becomes a situation of discretionarily exposing themselves as a stigmatized 
“other”.   As such, allowing others to find out is a common concern (Green et al., 2003; 
Newton & McCabe, 2008b), even among individuals who have never had physical signs 
of the virus (Rosenthal et al., 2006).   
 Individuals with genital herpes face the social ramifications of their disease when 
they disclose their genital herpes status to a potential partner (Bickford et al., 2007; 
VanderPlate & Aral, 1987).  Disclosure is the process of revealing one’s stigmatized 
condition and potentially positioning oneself as an “other” (Breitkopf, 2004).  Disclosure 
puts the person with genital herpes at risk for rejection.  Fear of rejection is one of the 
most commonly reported worries of individuals with genital herpes (Green et al., 2003; 
Melville et al., 2003; Newton & McCabe, 2008b).  Transcripts from herpes support chat 
rooms indicate that the most commonly asked questions address to whom and when to 
disclose (Gilbert & Omisore, 2009).  Disclosure becomes paramount when initiating 
relationships due to the risk of transmission, because genital herpes is highly 
transmissible through sexual contact.  As the partner is at risk for also acquiring the 
stigmatizing condition, this can fundamentally alter the relationship.  As part of the 
arsenal of prevention efforts to reduce the transmission of genital herpes, the Centers for 
Disease Control and Prevention (2010a) recommends that all individuals with genital 
herpes disclose their genital herpes status to potential partners prior to sexual initiation. 
Despite the potential for rejection, individuals with genital herpes disclose to 
partners for a variety of reasons.  Qualitative data suggest that some disclose for moral 
reasons, such as respect and honesty (Green et al., 2003; Lee & Craft, 2002; Newton & 
McCabe, 2008b).  Transitions in relationship seriousness, such as sexual progression of 
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the relationship or moving in together (cohabitation) can prompt disclosure (Green et al., 
2003; Lee & Craft, 2002; Newton & McCabe, 2008b).  Other people with genital herpes 
report ending relationships or slowing relationships down in order to avoid or delay 
disclosure (Lee & Craft, 2002; Newton & McCabe, 2008b).  People with genital herpes 
are also more likely to disclose if they expect a more positive response (e.g., a partner 
being understanding) as opposed to a negative response (e.g., disgust) from a partner 
(Green et al., 2003; Lee & Craft, 2002).  Some people with genital herpes conceptualize 
disclosure as part of disease prevention.  Gilbert, Scanlon, Peterson, and Ebel (2005) 
reported that 50% of individuals with genital herpes believed that disclosure was 
effective at reducing herpes transmission risk; although Green and colleagues (2003) did 
not find this to be a prominent reason for actual disclosure.   
Purpose 
Though the qualitative and mixed methods genital herpes disclosure literature has 
identified and discussed the many reasons as to why one does or does not disclose to a 
sexual partner, the relative importance of each of these factors has yet to be determined.  
This study quantifies issues highlighted in the qualitative literature to identify, among 
people with genital herpes, which factors are most important to genital herpes disclosure 
and non-disclosure, including the role of stigma and reaction expectations.  The purpose 
of this study was to 1) identify common reasons for disclosure and non-disclosure, 2) 
determine which individual and partner characteristics are associated with disclosure, and 
3) understand when in the romantic and sexual progression of a relationship disclosure 
occurs.   
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Methods 
 All study procedures and instruments were reviewed and approved by the lead 
author’s human subjects research/institutional review board (IRB).  
Participants and Procedures 
Individuals were invited to participate in a study about “Understanding Sexual 
Communication in Relationships” through a variety of online venues, including social 
media websites (e.g., Twitter, Facebook, Reddit, LinkedIn) and academic and 
professional email lists.  Interested individuals were asked to complete an initial set of 
questions to determine eligibility for study participation.  These initial questions served 
as a web-based screener for study inclusion criteria.  Individuals who identified as 18 
years old or older and as having genital herpes in the screener were then asked if they 
would be willing to participate in a study examining the impact of genital herpes on 
sexual relationship communication.  Individuals agreeing to participate gained access to 
the full online questionnaire. For the present study,1,622 people responded to the 
screener survey, between February 14th and May 1st, 2014. Of those individuals, 109 
qualified for the study after data cleaning for missing data (e.g., individual entered the 
survey but did not answer any questions) and duplicate cases (e.g., multiple entries from 
the same IP address within 1 hour of each other with minimal content differences).  After 
completing the screener, 105 agreed to participate. Data were further cleaned for invalid 
responses (e.g., reporting they answered dishonestly or reported the same value 
throughout large survey blocks irrespective of switches in the positivity or negativity of 
the question).  Only individuals 18+, self-reporting as having genital herpes, and who 
have reported having at least one oral, anal, or vaginal sex partner since realizing they 
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had genital herpes remained in the final dataset (N = 93).  Participants were offered the 
opportunity to be entered into a raffle for a $25.00 gift card for their time. 
Sample Demographics 
 The majority of participants identified as White (80.4%), female (79.6%), having 
a four-year college degree or higher (87.1%), and living in the United States (93.5%) 
(Table 1).  The sample primarily identified as heterosexual or straight (73.9%), with 
16.3% identifying as bisexual, 4.3% homosexual, gay, or lesbian, and 5.4% other.  Age 
ranged from 18 to 73 (M = 39.2, SD = 13.5).  The majority of participants accessed the 
survey through Facebook (47.3%) and email (42.9%). 
Instrumentation  
All items were developed after a comprehensive review of the literature.  Items 
underwent a multi-method, five phase pretesting period to assess validity and reliability.  
Phases included:  1) expert review, 2) cognitive interviews with the target population, 3) 
peer review, 4) role playing a fictional character through the questionnaire, and 5) a final 
round of cognitive interviews with the target population to assess changes made to item 
wording in previous phases.  Final item wording and response options reflect the findings 
from this pretesting process. 
Disclosure. Individuals who reported that they had at least one oral, sexual, or 
anal sex partner (since realizing they had genital herpes) were asked, “Did you tell the 
last person you had sex with that you have genital herpes?  This includes oral, anal, or 
vaginal sex.  This could be at any point in your sexual relationship with this person- 
telling could have occurred before or after sex. This could also be someone you are 
currently seeing.”  Response options included: No, and I don’t plan to tell them, No, but I 
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might tell them in the future, No, but I will definitely tell them in the future, and Yes.  The 
variable was dichotomized into Yes and No. 
 Individual-level variables.  Race/ethnicity, age, sex, sexual orientation, time (in 
months) since diagnosis, outbreak frequency, type of diagnosis, medication use, and 
stigma internalization were the individual-level predictors of disclosure explored.  
Several demographic variables were dichotomized to meet cell count expectations for 
bivariate analyses.  
Race/ethnicity was measured using the following question, “What is your 
race/ethnicity?  You may choose more than one option”.  Categories provided were 
White/Caucasian, Black/African American, Hispanic/Latino, Asian, Native American, 
Pacific Islander, and Other.  For analyses, the variable was recoded into 
White/Caucasian (only) versus Other racial/ethnic category.   
Age was measured as a continuous variable in which individuals typed in a 
numerical response to the question “What is your age?”  
Sex was measured by the question “What is your sex?” with response options of 
Male, Female, and Other.   
Sexual orientation was measured using the item “What is your sexual 
orientation?” with response options of Heterosexual or straight, Bisexual, Homosexual, 
gay, or lesbian, and Other.  Values were dichotomized into Heterosexual or straight and 
Other for analysis to meet bivariate cell count expectations.  
Time since diagnosis (in months) was calculated by converting responses from 
the question “When did you find out that you had genital herpes?”, which had a drop-
down selection menu for month and year into a continuous months since diagnosis 
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variable.  Time since diagnosis was calculated by establishing the difference between the 
survey start date and the month and year provided.  For the six individuals who did not 
provide a month, but only a year, the midpoint of June of that year was utilized for 
calculations.   
Outbreak frequency was measured using the item “Approximately how often do 
you have herpes outbreaks?” with response options of I have never had an outbreak or 
genital herpes symptoms, I haven’t had an outbreak since my very first time getting 
genital herpes, Less than once a year, 1 to 2 times a year, 3 to 5 times a year, and 6 or 
more times a year.  Outbreak frequency was dichotomized for analyses to Less than once 
a year and At least once a year to reflect individuals who consistently have symptomatic 
outbreaks and those who do not.   
Medication use was measured by the item “Do you take any medication for 
genital herpes?” with the response options of Yes, daily suppressive treatment to prevent 
outbreaks, Yes, when I notice signs of an outbreak or during an outbreak to shorten its 
length, No, and Other (Please describe).  Individuals who selected the “Other” option and 
indicated they were past users of medication but not current users were recoded as “No.”  
The variable was dichotomized for analyses into Daily suppressive medication and Other, 
as daily suppressive medication can reduce the risk of genital herpes transmission 
(Centers for Disease Control and Prevention, 2010a).   
Condom use was measured by the item “Since discovering you had genital 
herpes, how often have you used condoms when having anal or vaginal sex?” with 
response options on a 5 point scale ranging from 1 = Never to 5 = Always.   
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Herpes stigma internalization was measured using an adapted version of the 
revised HIV Stigma Scale (Wright et al., 2007), including 12 items measured on a 5 point 
scale from 1 = Strongly disagree to 5 = Strongly agree.  Higher mean scores indicate 
higher herpes stigma internalization.  In the present study, the scale demonstrated good 
internal consistency reliability (Cronbach α = .91).    
Partner characteristics. Time in relationship, relationship type, and anticipated 
partner reaction were examined. Time in relationship was measured by the item 
“Approximately how long did or has your sexual relationship last(ed) with this person?” 
divided into time categories of Less than 1 week, 1 week to less than 1 month, 1 month to 
3 months, 4 to 6 months, 7 months to less than 2 years, 2 to 5 years, and  6+ years. These 
categories emerged as meaningful relationship time demarkers during the multi-phase 
pretesting of the survey instrument according to pretesting interviews and critiques.  For 
analyses, these time categories were recoded into Less than 1 week to 3 months, 4 months 
to less than 2 years, and 2 years or more to reflect longer and shorter term relationships 
while adequately meeting expected cell counts necessary for analysis.  Relationship type 
was measured by the item “How would you best describe your relationship with the last 
person you had sex with at the time you last had sex?”  Response options were One night 
stand, Booty call, Friends with benefits, Dating, Boyfriend/girlfriend, Fiancé, 
Husband/wife, an ex, and Other.  Responses were recoded into the bivariate categories of 
socially committed and not socially committed.  Respondents who reported their 
relationship type as girlfriend/boyfriend, husband/wife, longtime partner, or checked 
“Other” and described a long term committed relationship (e.g., committed partner of 25 
years) were recoded as socially committed.  Individuals who reported their relationship 
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type with the last person they had sex with as booty call, friends with benefits, dating, an 
ex, and second lover were recoded as not socially committed for analyses.  Finally, 
anticipated partner reaction was measured via a single item for both disclosers and non-
disclosers at last sex on a scale from one to five (1 = Very positively to 5 = Very 
negatively).  Disclosers were asked “BEFORE you told the last person you had sex with 
about having genital herpes, how did you EXPECT your partner to react to telling 
them?”  Non-disclosers were asked “In your opinion, how do you EXPECT the last 
person you had sex with would have reacted if you had told them about having genital 
herpes?”.  Reponses from both items were combined into a single disclosure expectation 
variable. 
Data Analysis 
Data were exported from the online survey system Qualtrics (Qualtrics, 2013) and 
analyzed using SPSS version 22 (IBM Corp., 2013).  Bivariate associations with 
disclosure were explored using chi-square and Fisher’s Exact tests for categorical 
variables, and continuous variables were analyzed using independent means t-tests.  
Characteristics associated with disclosure at the bivariate level were entered into a 
logistic regression model to examine the relative importance of various individual and 
relationship characteristics for explaining disclosure outcomes.  Backward elimination 
using the Wald statistic determined statistically significant predictors of disclosure.  All 
analyses were assessed at the p < .05 significance level, and odds ratios and 95% 
confidence intervals were reported for all logistic regression analyses.   
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Results 
 The majority of participants (80.4%) disclosed.  Age was the only individual-level 
characteristic associated with disclosure at the bivariate level, t(90) = 2.78, p = .007 
(Table 2).  The mean age for individuals who reported not disclosing at last sex was 
31.44 years (SD = 11.70), and the mean age for individuals who did disclose was 40.93 
years (SD = 13.32).   
All relationship variables were statistically significantly associated with 
disclosure at last sex (Table 2).  Relationship type was associated with disclosure to one’s 
last sexual partner (p = .003). Respondents who reported being in socially committed 
relationships, such as boyfriend/girlfriend, husband/wife, and longtime partners were 
more likely to have disclosed than those in non-socially committed relationships.  Time 
in relationship was also associated with disclosure to one’s last sexual partner, Χ2(2) = 
7.47, p = .024.  Respondents reporting shorter relationship lengths (less than one week to 
three months) disclosed at lower rates than those in relationships lasting two or more 
years. Expectations of a partner’s reaction to a disclosure was also associated with the 
decision to disclose; respondents who did not disclose expected their partner to react 
more negatively than those who did disclose, t(49.2) = -5.64, p < .001. 
 When predicting disclosure in the binary logistic model, expectations of a 
partner’s reaction (AOR = .20, 95% CI .074-.539) and relationship type (AOR = 8.31, 
95% CI 1.96-35.32) remained significant, explaining 45.2% of the variance in disclosure.  
For each one point increase on the expectations scale towards a more negative reaction, 
the odds of disclosure decreased by 80%.  Individuals in socially committed relationships 
had 8.31 greater odds of disclosure than those not in socially committed relationships. 
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 To address the third purpose of the paper, to understand disclosure timing, 
bivariate relationships between romantic and sexual relationship activities and disclosure 
were examined, and frequencies of disclosure prior to these activities are presented.   
There were several differences in the sexual and relationship progression between 
respondents who reported disclosure and those who did not.  Respondents who disclosed 
were significantly more likely to have: gone on a first date (p = .003), stopped dating 
other people (p < .001), said “I love you” (p = .020), reported their partner said “I love 
you” (p = .008), got engaged (p = .030), and got married (p = .025) to their last sexual 
partner than expected by chance alone.  Regarding the sexual progression of the 
relationship, only participating in anal sex had a significant association with disclosure (p 
= .030).  Those who reported anal sex with their last sexual partner reported higher levels 
of disclosure with their last sexual partner than expected.   
Many individuals who disclosed did not do so until after they had engaged in 
numerous relationship building and sexual activities with their last sexual partner (Figure 
1).  Among those who reported disclosure at some point to their last sexual partner and 
who reported receiving oral sex (n =56), 58.9% disclosed prior to receiving oral sex.  The 
prevalence of disclosure prior to receiving oral sex among those who received oral sex 
was higher than the prevalence of disclosure before performing oral sex (45.6%) among 
those who reported performing oral sex.  Among those who disclosed and reported 
having vaginal sex (n =58), 58.6% disclosed before engaging in vaginal sex.  
Approximately 56% of those who reported having anal sex and disclosing to their partner 
(n=32) disclosed prior to engaging in anal sex. 
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 The majority of respondents selected more than one reason for their decision to 
disclose (Range 0 to 9, M = 6.76, SD = 3.41) or not disclose (Range 0 to 15, M = 5.22, 
SD = 2.41) (Table 3).  Individuals were asked to select all of the reasons they decided to 
tell their last sex partner about having genital herpes, as well as what was their primary 
reason for disclosure was.  The most common reasons reported for disclosure when asked 
to select the primary reason for disclosure were I wanted to be honest; To protect my 
partner from getting herpes; and It’s my partner’s right to know.  Among those who did 
not disclose to their last sex partner, when asked to select a primary reason for non-
disclosure the most common reasons were I was concerned my partner would react 
badly; I was ashamed; and I was concerned that my partner would have rejected me.  
There was more dispersion of primary reasons among those who did not disclose 
compared to those who did. 
Discussion 
 The purpose of this study was three-fold.  First, the goal was to understand the 
relative importance of various reasons for and against disclosure highlighted in the 
qualitative literature.  Second, it was to determine what individual and partner level 
statistics are significantly associated with the decision to disclose.  The third purpose was 
to better understand the role of disclosure timing in the decision to disclose. 
The current study confirms several themes found throughout the qualitative and 
mixed methods research on genital herpes disclosure.  Similar to previous qualitative 
studies, common reasons for disclosure were a partner’s right to know and honesty (Lee 
& Craft, 2002; Newton & McCabe, 2008b).  Also, confirming findings from qualitative 
literature (Green et al., 2003; Newton & McCabe, 2008b), the most common reasons for 
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non-disclosure were based on expectations that a partner would react negatively to the 
disclosure, with the majority of participants reporting that fear of rejection and a partner 
reacting badly were the primary reasons for non-disclosure. Contrary to conclusions by 
Green et al. (2003), a desire to protect one’s partner from genital herpes was commonly 
selected as a primary reason for disclosure.   
 Study findings suggest that relationship characteristics are more important than 
individual characteristics in the decision to disclose.  All relationship level characteristics 
including relationship type, time in a relationship, and expectations of the potential 
negativity of a partner’s reaction were associated at the bivariate level, whereas age was 
the only individual-level predictor of disclosure at the bivariate level.  When predicting 
disclosure in multivariable analyses, only relationship level characteristics remained 
significant with relationship type and expectations of a partner’s reaction accounting for 
45.2% of the variance in disclosure decision.  Unlike previous work by Bickford and 
colleagues (2007), stigma was not significantly associated with genital herpes disclosure. 
As a relationship becomes more serious and committed, individuals are more 
likely to disclose.  Individuals who reported their relationship with their last sex partner 
as being one that is more socially committed, such as husband/wife, boyfriend/girlfriend, 
or longtime partner were more likely to disclose.  Individuals in longer relationships were 
also statistically more likely to disclose than those in shorter relationships.  This pattern 
of increased disclosure among individuals in more committed relationships can also be 
seen through examining disclosure within the romantic and sexual progression of a 
relationship.  Among individuals who demonstrated a more romantic pattern of 
relationship building, including relationship milestones such as a first date, exclusivity, 
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an engagement, or marriage, disclosure was reported more than expected.  This is 
consistent with findings by Green and colleagues (2003), which suggest that relationship 
milestones may prompt disclosure, and that disclosure is more likely to occur in serious, 
longer term, and committed relationships (Bickford et al., 2007; Green et al., 2003).  
This pattern did not hold true, however, for individuals in the sexual progression 
of a relationship.  If conceptualizing sexual progression as a series of acts that lead up to, 
or culminate, in penetrative sex, which is disputable, there was not a statistically 
significant association with sexual progression and disclosure.  Patterns of disclosure 
matched expectations for disclosure distributions, with the exception of anal sex.  Among 
individuals who disclosed and reported participating in the following activities with their 
last sex partner, 20% disclosed before the first kiss, 33.9% before they stimulated their 
partner’s genitals with their hands, 40.7% before their partner stimulated them with their 
hands, 45.6% before performing oral sex on their partner, 58.9% before they received 
oral sex from a partner, 58.6% before vaginal sex, and 56.3% before anal sex.  There is a 
clear trend with disclosure with more “serious” forms of sexual interaction.  Perception of 
transmission risk may also affect the decision to disclose as individuals are less likely to 
disclose before providing digital and oral stimulation to a partner and demonstrate 
increased disclosure before their partner performed these same activities.  However, rates 
of disclosure after sex fall within the wide range of disclosure timing among other studies 
of sexually transmitted infection disclosure, which found anywhere between 16% (HIV 
disclosure among men who have sex with men and women) and 69% (genital wart 
disclosure among clinic attendees) of disclosures occur after sex (Green et al., 2003; 
Keller et al., 2000; McKay & Mutchler, 2011, Scrivener et al., 2008; Wald et al., 2006).  
60 
 
Collectively, these diverse rates of disclosure after sex suggest that when to disclose may 
be impacted by different characteristics than the global decision to disclose. 
 The expectation that a partner would react negatively was an important expressed 
reason for why individuals in this study did not disclose, with almost 9 in 10 non-
disclosers reporting that I was concerned my partner would react badly and I was 
concerned that my partner would have rejected me.  Participants who did not disclose 
also reported a more negative expectation of their partner’s reaction (M = 3.28 vs. M = 
4.47), indicating that many more non-disclosers felt their partner would react very 
negatively.  Additionally, the odds of disclosure decreased by 80% for each one point 
increase on the negativity scale in the logistic regression model.  Though the majority of 
individuals who disclosed expected their partner would react somewhat negatively, the 
majority of individuals who did not disclose indicated that their partner would react very 
negatively. As such, simply expecting a negative reaction does not prevent disclosure.  
However, the extent of the expected negativity may have had considerable impact on the 
decision to disclose. These findings corroborate findings in the HIV literature, which 
suggest expectations of a negative partner response are associated with lower levels of 
disclosure (Obermeyer, Baijal, & Pergurri, 2011).  Future studies should examine what 
constitutes a “very negative” response and assess how reliably individuals can predict 
receiving a response of this type. 
In order to increase overall levels of disclosure, it is important to address positive 
sexual communication in sexual relationships, broadly defined.  Three-quarters of non-
disclosers reported that one of the contributing reasons for not disclosing was that They 
didn’t ask.  This informal policy of “Don’t ask, don’t tell” can also be found in HIV 
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disclosure literature (Gorbach et al., 2004).  As such, it is important to highlight that 
starting sexual health conversations should be both partners’ responsibility, not just the 
partner who has something to disclose.  The assumption that an individual with an STI 
will automatically disclose to sexual partners needs to be addressed in sexual health 
programming; just because a conversation about STIs has not occurred in a sexual 
relationship does not necessarily mean that neither party has something to discuss.  The 
burden of the disclosure conversation should not be placed solely on those with an STI, 
as this can increase the fear and anxiety associated with telling a partner. Disclosure 
should occur within a broader conversation about the desire for sex, sexual likes and 
dislikes, and protections to be used. Therefore, sexual communication skills are necessary 
for both parties.  Teaching strategies and techniques to address this topic in a variety of 
sexual relationships is essential, as oftentimes these conversations only happen among 
committed or romantic partners due to their structure and need for trust to be apparent 
(Green et al., 2003). The same in-depth conversation approach may not be appropriate for 
more casual relationships. 
 Disclosure timing is another area to explore and address.  Among individuals who 
disclosed in this study, the disclosure often occurred after engaging in sexual activities 
that could potentially transmit genital herpes.  More than 40% of individuals who 
disclosed did so after receiving oral sex, or engaging in vaginal or anal sex.  This is 
similar to previous studies of genital herpes disclosure after sexual initiation (46%; Wald 
et al., 2006) and genital warts disclosure after sexual intercourse (31%; Keller et al., 
2006).  In research examining partners’ reactions to disclosure, Williams (2009) found 
that disclosing one’s genital herpes status after engaging in sexual activity was viewed 
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more negatively, often leading to feelings of resentment with the perception of being lied 
to.  For both psychological and biological reasons, it is better to disclose one’s STI status 
prior to engaging in sexual activity.  Future studies should seek to understand disclosure 
timing better. This study is not devoid of limitations. This study is a cross-sectional, 
anonymous online survey; therefore, causality cannot be determined.  However, findings 
largely corroborate themes identified in qualitative literature, and as such provide a more 
robust understanding of the nature of genital herpes disclosure.  Sample limitations also 
exist.  For example, participants were recruited through online venues, including personal 
and professional contacts through email lists and social media sites, resulting in a 
convenience sample that is largely well-educated, White, and female.  Many of the 
respondents reported being in steady committed relationships, including 43% describing 
their last sex partner as husband/wife.  As such, the sample is not representative of all 
individuals with genital herpes and may not be similar to individuals who are single and 
still actively navigating dating, or who are men, less educated, and members of minority 
communities.   
However, participants in the present study did not self-select to be in a genital 
herpes specific study, as the research was advertised more broadly as a study about 
understanding sexual communication in relationships, potentially enhancing sample 
validity and diversity.  This study also adds to the body of literature on genital herpes 
disclosure, as the recruitment method potentially taps into a segment of the genital herpes 
population not previously reached through studies which recruited from clinics and 
support groups, both electronic and physical.  Finally, this is the first study of genital 
herpes disclosure using a primarily U.S. sample, which could potentially have important 
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implications for stigma, as perceptions of sex in the U.S. often are more conservative 
than other industrialized nations. 
 This study builds on previous work, confirming the robustness of many of the 
dominant themes in the qualitative literature regarding reasons for genital herpes 
disclosure.  In addition to confirming dominant themes, the relative relationship between 
different predictors of disclosure were established, clearly demonstrating the need to 
analyze disclosure in the context of a partner specific basis, rather than an individual 
identity and decision making process.  These findings have important implications for 
individuals trying to increase disclosure rates.  Individuals who expect a very negative 
reaction are less likely to disclose to a partner, regardless of length of relationship.  
Sexual health promotion and STI interventions should focus on expectation management 
in order to increase disclosure rates across relationship types.   
Findings also have important implications for reducing the transmission of genital 
herpes via disclosure.  Results from the present study suggest that successful disclosure 
often occurs after one has already engaged in numerous sexual activities that can transmit 
the herpes virus.  As such, positioning disclosure as a herpes prevention method fails to 
capture the core reasons individuals do and do not disclose.  Individuals seeking to 
reduce transmission rates should likely focus on other prevention avenues to reduce 
transmission.  Findings from the current sample suggest that increasing the use of 
condoms and suppressive therapy might be the most efficient ways to address 
transmission, as use of both of these methods was low among the current sample, despite 
their proven benefits without necessitating disclosure prior to sexual activity. 
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Tables and Figures 
Table 1:  Demographic characteristics of the sample (N =93) 
Demographic Variable n % 
Sex (n = 93) 
  
 
Male 19 20.4 
 
Female 74 79.6 
Race/Ethnicity (n = 92) 
  
 
White 74 80.4 
 
Black/African American 4 4.3 
 
Hispanic/Latino 7 7.5 
 
Other 7 7.6 
Education (n = 93) 
  
 
High School / GED 2 2.2 
 
Some college 10 10.8 
 
2-year college degree 4 4.3 
 
4-year college degree 20 21.5 
 
Masters degree 35 37.6 
 
Doctoral or Professional (JD, MD) degree 22 23.7 
Sexual Orientation (n = 92) 
  
 
Heterosexual or straight 68 73.9 
 
Bisexual 15 16.1 
 
Homosexual, gay, or lesbian 4 4.3 
 
Other 5 5.4 
Country of Residence (n = 92) 
  
 
United States 86 93.5 
 
Other 6 6.5 
Relationship Type at Last Sex (n = 86) 
  
 
Booty call 5 5.8 
 
Friends with benefits 6 7.0 
 
Dating 6 7.0 
 
Boyfriend/girlfriend 22 25.6 
 
Fiancé 4 4.7 
 
Husband/wife 37 43.0 
 
Other 6 6.5 
Relationship Length with Last Sex Partner (n= 81) 
 
 
≤ 3 months 10 12.3 
 
4 to 6 months 5 6.2 
 
7 months to less than 2 years 9 11.1 
 
2 to 5 years 23 28.4 
 
6+ years 32 39.5 
Age (n = 93)        Range: 18 to 73 M = 39.2 SD = 13.5 
 
65 
 
Table 2: Bivariate comparisons of individual and partner characteristics with disclosure 
at last sex 
                                                                                            Disclosed to Last Sex Partner 
Individual Level 
 
                 n 
 
 Yes     No 
Race 
      
 
White 
 
n= 73 82.2% 17.8% p = .339a 
 
Other  
 
n= 18 72.2% 27.8% 
 Sex 
      
 
Female 
 
n= 74 79.7% 20.3% p = 1.00a 
 
Male 
 
n= 18 83.3% 16.7% 
 Sexual Orientation 
    
 
 
Heterosexual or straight n= 67 82.1% 17.9% p = .552a 
 
Other 
 
n= 24 75.0% 25.0% 
 Education 
      
 
4 year college degree or higher n= 81 80.2% 19.8% p = 1.00a 
 
Less than a 4 year degree n= 11 81.8% 18.2% 
 First discovery 
     
 
Concerning symptoms 
 
n= 85 80.0% 20.0% p = 1.00a 
 
Positive herpes blood test 
 
n= 6 83.3% 16.7% 
 Diagnosis Type 
     
 
Doctor or nurse 
 
n= 80 81.2% 18.8% p = .412a 
 
Self-diagnosis only 
 
n= 10 70.0% 30.0% 
 Medication use 
     
 
Daily suppressive 
 
n= 15 86.7% 13.3% p = .726a 
 
Other 
 
n= 67 80.6% 19.4% 
 Outbreak Frequency 
     
 
Less than once a year n= 49 79.6% 20.4% p = .546b 
 
At least once a year 
 
n= 33 84.8% 15.2% 
 Condom Use 
     
 
Most times/Always 
 
n= 27 81.5% 18.5% p = 1.00b 
 
Sometimes/Rarely/Never n= 54 81.5% 18.5% 
 Time Since Diagnosis (months) 
 
n= 92 145.4 (126.8) 93.4 (84.2) p = .055 
Internalized Herpes Stigmac 
 
n= 82 2.7 (0.9) 3.2 (0.8) p = .079 
Age  n= 92 40.9 (13.3) 31.4 (11.7) p = .007 
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Table 2: Bivariate comparisons of individual and partner characteristics with disclosure 
at last sex (continued) 
Partner Level           
Relationship Commitment 
     
 
Socially Committed 
 
n= 65 87.7% 12.3% p = .003a 
 
Not Socially Committed n= 20 55.0% 45.0% 
 Time in Relationship 
     
 
Less than 1 week to 3 months n= 12 50.0% 50.0% p = .024d 
 
4 months to 2 years 
 
n= 14 78.6% 21.4% 
 
 
2 years or longer 
 
n= 55 85.0% 14.5% 
 Partner Reaction Expectationse 
 
n = 81 3.3 (1.2) 4.5 (0.6) p < .001 
 
 
Note. Row percents are provided for all categorical variables.  Means and standard 
deviations are provided for continuous variables.  a. Due to an expected cell count of less 
than 5 in at least one cell, a Fisher’s Exact test was performed. b. A Pearson’s chi-square 
statistic is reported. c. The Internalized Herpes Stigma scale is a mean score that ranges 
from 1 to 5, with higher scores indicating a higher internalized herpes stigma.  d. Despite 
having a least one cell with an expected count of 5, a Pearson’s chi-square statistic was 
used.  e. Partner Reaction Expectations is on a scale ranging from 1 = Very positively to 
5 = Very negatively.  
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Table 3: Reasons for disclosure and non-disclosure with one’s last sexual partner 
_________________________________________________________________ 
Reasons for disclosure (n=68) 
 
 
I wanted to be honest 92.6% 
 
It is my partner's right to know 89.7% 
 
I cared about my partner 88.2% 
 
I trusted my partner 82.4% 
 
To protect my partner from getting herpes 80.9% 
 
I expected my partner would be understanding 75.0% 
 
I felt bad about keeping a secret 41.4% 
 
Our relationship became more serious 39.7% 
 
I thought my partner would find out anyway 38.2% 
 
I felt guilty 29.4% 
 
I needed the emotional support 23.5% 
 
Because I had an outbreak 19.1% 
 
I thought they gave it to me 16.2% 
 
My partner wanted to stop using condoms 11.8% 
 
Other 9.4% 
 
I had been drinking alcohol 2.9% 
   Reasons for non-disclosure (n=17) 
 
 
I was concerned my partner would react badly 88.2% 
 
I was concerned that my partner would have rejected me 88.2% 
 
I was ashamed 82.4% 
 
They didn't ask 76.5% 
 
It wasn't a serious relationship 41.2% 
 
I was concerned my that partner would end the relationship 35.3% 
 
I was concerned that the information would spread to others 35.3% 
 
Other 33.3% 
 
I used condoms 29.4% 
 
It was none of my partner's business 17.6% 
 
I ended the relationship so that I didn’t have to tell them 17.6% 
 
I was on daily herpes medication to prevent outbreaks 11.8% 
 
We did not have vaginal or anal sex 11.8% 
__________________________________________________________________ 
Note. Participants could select more than one option. 
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Figure 1.  Disclosure timing among those who disclosed.  Figure represents disclosure 
timing across a variety of sexual and relationship milestones among individuals who 
reported disclosing at some point to their last sexual partner.  Numbers represent the 
number of respondents who indicated they disclosed before the activity occurred in the 
relationship, after the activity occurred in the relationship, if they are not sure whether or 
not they disclosed before or after this activity occurred, or whether this activity never 
occurred with the last person they had sex with. 
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Genital Herpes Disclosure: Outcomes, Rejection, and Future Intentions to Disclose 
 
Abstract 
 
Objectives:  To examine partner reactions to genital herpes disclosure and how partner 
reactions influence future intentions to disclose. Methods:  Participants 18+, who had a 
past disclosure experience to a potential sexual partner (N = 86), completed a web-based 
questionnaire about their experiences with genital herpes disclosure.  Results:  The 
majority of participants (>95%) felt that their partner responded either neutrally or 
positively after their last disclosure, and perceived rejection was low (<5%). Two out of 
three individuals who reported rejection did not report a negative partner reaction.  
Among participants who intended to have a future sexual partner, disclosure intentions 
were high, with 88% reporting they were likely or very likely to disclose in the future.  
Conclusions:  When participants decided to tell partners about having genital herpes, 
their disclosure was generally well-received, despite pervasive fears that a partner would 
react negatively.  Preliminary findings support current health promotion messages about 
genital herpes disclosure. 
Introduction 
Genital herpes is one of the most common sexually transmitted infections (STIs) 
in the U.S. (Centers for Disease Control and Prevention, 2010a).  Both herpes simplex 
virus type 1 (HSV-1) and type 2 (HSV-2) can present in the genital region of the body 
(Centers for Disease Control and Prevention, 2010a).  Data from the National Health and 
Nutrition Survey estimate the national prevalence of HSV-2 for 2005-2008 at 16.2% (Xu 
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et al., 2010).  HSV-2 prevalence provides a conservative estimate of genital herpes 
prevalence, as HSV-1 is a growing contributor of genital herpes cases (C. M. Roberts et 
al., 2003; Xu et al., 2006).  The Centers for Disease Control and Prevention (CDC) 
estimates that up to 50% of first-episode genital herpes cases are attributed to HSV-1 
infection (Centers for Disease Control and Prevention, 2006).  
Overall, genital herpes is a relatively benign condition from a medical standpoint 
(Green, 2004).  Studies have consistently documented that the social aspects of the virus 
are considerably more burdensome than its physical manifestations (Green et al., 2003; 
Melville et al., 2003).  Numerous negative psychosocial consequences have been 
associated with a genital herpes diagnosis including depression (Beauman, 2005), anxiety 
(Beauman, 2005; Oster & Cheek, 2008), feelings of unworthiness (Newton & McCabe, 
2008b), decreased feelings of sexual attractiveness (Mindel, 1993; Newton & McCabe, 
2008b), and fear (Lee & Craft, 2002; Mindel, 1993).  The most frequent consequence of a 
herpes diagnosis is a reduction or complete withdrawal from sexual activity (American 
Social Health Association, 2000).  Individuals indicate that living with the stigma 
associated with herpes is hardest part of having the disease (Lee & Craft, 2002; Melville 
et al., 2003; Mindel, 1993; Richards et al., 2008).  Herpes symptoms can be treated, but 
herpes cannot be cured (Richards et al., 2008).  As a result, the stigma remains with 
someone for life.   
 Disclosure of a genital herpes status to a potential partner is one strategy 
promoted to reduce genital herpes transmission (Wald et al., 2006).  As genital herpes is 
an incurable STI, individuals with genital herpes face the decision to disclose their status 
to their partner with each new relationship formed.  Such disclosure places individuals 
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with genital herpes in a position to face rejection.  Existing studies suggest that fear of 
rejection is one of the most concerning aspects of having genital herpes (Green et al., 
2003; Keller et al., 1991; Melville et al., 2003).  Mark et al. (2009) found that 54.4% of 
women newly diagnosed with genital herpes reported fearing that others would reject 
them if they found out about their genital herpes diagnosis.  VanderPlate and Aral (1997) 
indicated the source of genital herpes stress is disclosure, as this is the time when one 
must face the social realities of the disease and confront their own fears concerning it.   
 Though studies have consistently highlighted the fear of rejection as an important 
element in genital herpes disclosure, no research has systematically examined the results 
of disclosure to see if the fear of rejection has been realized.  Most studies that include 
data about partner reactions to a disclosure do so within a broad discussion of disclosure 
and psychosocial adjustment in qualitative findings (Lee & Craft, 2002; Newton & 
McCabe, 2008b).  Within the existing genital herpes disclosure research, questions about 
partner reactions and feelings of rejection are not consistently examined across study 
participants.  To the best of our knowledge, only one study has systematically asked 
about disclosure outcomes specifically.  Green and colleagues (2003) reported that 22 
respondents reported “good reactions”, while five reported “adverse” outcomes to 
disclosure in their mixed methods investigation into genital herpes and determinants of 
disclosure.  However, what constituted a “good” versus “adverse” outcome was not 
described, and perceptions of rejection were not measured.   
The purpose of the present study was to examine perceptions of partner reactions 
to a disclosure, identify common reactions to a disclosure, understand which reactions are 
associated with feelings of rejection, and describe how such perceptions impact future 
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intentions to disclose among adults with genital herpes.  Understanding disclosure 
outcomes has important implications for health messaging regarding stigma reduction 
and expectation management, especially in regards to reducing the psychosocial burden 
of genital herpes.  Furthermore, exploring the relationship between past disclosure 
outcomes and future intentions to disclose might help explain some of the reasons 
inconsistent patterns of disclosure exist and why individuals are least likely to disclose to 
one’s most recent partner. 
Methods 
This study was approved by the University of South Florida Institutional Review 
Board. 
Participants and Procedures 
  Data were collected via an anonymous, online questionnaire.  A link to the online 
questionnaire was posted by study personnel on a various online venues, including 
Facebook, Twitter, and Reddit, and was distributed through professional and academic 
email lists between February 17th and May 1st, 2014.  It additionally was distributed 
electronically by individuals who saw the link, resulting in a type of snowball distribution 
of the link through social media and email channels.   
Participants were invited to take part in an online study about “Understanding 
Sexual Communication in Relationships”.   Interested individuals ages 18 and older were 
asked to complete an online screener to determine study eligibility.  Respondents who 
identified as 18 years or older and reported having genital herpes were permitted access 
to the full study questionnaire and qualified for an opportunity to be entered into a raffle 
for a $25.00 gift card for their time.  Of the 1,622 individuals who completed the screener 
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questionnaire, 115 met initial inclusion criteria and then qualified for study participation.  
Of those who gained access to the full study questionnaire, 110 agreed to participate in a 
study that focused on the role of genital herpes in sexual communication.  After data 
cleaning for duplicative respondents (n = 5), a preponderance of missing data (n = 10) 
and questionable or invalid response patterns (n = 2) (i.e., answering “3” regardless of 
question type or reporting they never had genital herpes after indicating they did), 86 
individuals ages 18 and older with genital herpes who reported telling at least one 
potential romantic and/or sexual partner were included in the final analysis. 
Instrumentation 
 The online questionnaire was developed through a rigorous pretesting process.  
First, items were developed from existing disclosure literature.  Next, the questionnaire 
underwent a five phase, multi-method pretesting procedure to assess validity and 
reliability.  The sequential pretesting phases included: expert review, cognitive interview 
with individuals with genital herpes, peer review, role playing, and a final set of cognitive 
interviews with the target population to assess changes made throughout the pretesting 
period.   
The questionnaire was split into two phases: the initial screener and the core study 
questionnaire.  The screener contained demographic questions.  The second part of the 
questionnaire was herpes-specific, focusing on experiences with genital herpes and 
disclosure of genital herpes to sexual partners.  Analyses focus on an individual’s last 
disclosure experience with someone in whom they were romantically or sexually 
interested.   
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Disclosure Reactions.  The overall perception of a partner’s response was 
measured by the question, “Overall, how would you classify [your partner’s] reaction 
when you told them you had genital herpes?” on a scale from 1 = Very positive to 5 = 
Very negative.    Specific disclosure reactions were measured via 25 items which reflected 
both positive and negative reactions highlighted in qualitative literature.  These items 
were measured on a 5 point scale from 1 = Strongly disagree to 5 = Strongly agree.   
Rejection.  Perception of rejection (yes/no) was measured by the item “Did your 
partner’s reaction to telling them about having herpes make you feel rejected?”.   
Future Disclosure Intentions.  Future intentions to disclose was measured by the 
item “How likely are you to tell your next sexual partner that you have genital herpes?” 
with response options including Very likely, Likely, Undecided, Unlikely, Very unlikely, 
and I do not intend on having another future sexual partner.  Individuals who indicated 
they did not intend to have another future sexual partner were excluded from analyses 
examining future intentions to disclose. 
Data Analysis 
Data were exported from Qualtrics survey software (Qualtrics, 2013) to SPSS 
(version 22) statistical software (IBM Corp, 2013) for data analysis.  Reactions to 
disclosure are presented using descriptive statistics, including frequencies and means.  
Associations between partner reactions and future intentions to disclose were examined 
using Spearman correlations.  Associations between perceived rejection and future 
intentions to disclose were examined using chi-square analyses.  All analyses were 
examined at the p < .05 level.   
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Results 
 Sample demographics are displayed in Table 1.  Respondents were predominantly 
White (80%), female (79.1%), well-educated (83.7% with a 4 year degree or higher) and 
living in the United States (91.4%).  Age ranged from 19 to 73 years (M = 40, SD = 
13.6). Participants reported accessing the survey primarily through Facebook (50.6%) 
and email (41.2%), with 3.5% reporting Twitter and 4.7% reporting “Other website”.   
The majority of participants who answered the question (n = 69) about a partner’s 
overall reaction reported that the last person with whom they were sexually or 
romantically interested responded “Neither positively nor negatively” (34.8%), 
“Somewhat positively” (29%), or “Very positively” (31.9%) to the disclosure.  Only 3 
respondents (4.3%) indicated the person to whom they disclosed reacted negatively or 
very negatively.   
Similarly, 3 participants out of 68 (4.4%) indicated that their partner’s reaction 
made them feel rejected.  However, only one of the respondents who reported feeling 
rejected assessed their partner’s overall response as “Somewhat negative” or “Very 
negative”.  The two others assessed their partner’s reaction as “Somewhat positive” and 
“Neither positive nor negative”.   
Participants expected their partners to react more negatively than they assessed 
their actual reactions.  Though 42% of participants expected their partner to react 
“Somewhat negatively” prior to disclosing, 96% of the sample rated their partner’s 
reaction as “Neither positive nor negative” or better after disclosing (Figure 1).  
Expectations were significantly correlated with outcomes, (rs[69] = .389, p < .001), 
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indicating that respondents who expected a more negative reaction reported their partner 
responding more negatively. 
Partner reactions are presented in Table 2.  Among negative reactions, “needed 
time to think about where the relationship was headed” and “was more cautious around 
me” had the highest mean scores, M = 2.06 and M = 1.95 respectively, indicating more 
diversity among these two reactions.  The majority of participants agreed or strongly 
agreed with the statement that their partner “appreciated the honesty” (77.3%) and “was 
understanding” (83.6%).  
Sex with the last person the respondent disclosed to was common. Only 3 
respondents reported not participating in any type of sex with the last person to whom 
they disclosed.  The majority of participants reported having oral (90.1%) and vaginal 
(92.9%) sex with the last person to whom they disclosed.   
Disclosure intentions were high.  The majority of participants reported that they 
did not intend on having a future sex partner (48.7%) or were very likely (38.2%) to 
disclose to their next sexual partner.  Among respondents who intended to have a future 
sexual partner, 3 reported they were “Very unlikely” to tell their next sexual partner, 1 
was “Unlikely”, 2 were “Undecided”, 1 was “Likely”, and 29 were “Very likely” to 
inform their next sexual partner, meaning 80.5% of individuals who were open to the idea 
of having a future sex partner were “Very likely” to disclose in the future. 
Due to low rates of negative partner reactions and low rates of reported rejection, 
statistical associations between last disclosure experience and future intentions to disclose 
were not feasible.  All participants who reported a somewhat negative (n = 2) or very 
negative (n =1) overall partner reaction to their last disclosure reported not intending on 
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having a future sexual partner.  Beyond the overall impression of a partner’s reaction, 
there were no statistically significant correlations between individual types of reactions to 
a disclosure and future intentions to disclose, due to limited variability in intentions to 
disclose.  Regarding rejection and future disclosure intentions, 2 out of 3 of the 
respondents who reported feeling rejected after their last disclosure also reported not 
intending on having a future sex partner; the last individual who reported feeling rejected 
reported she was  “Very likely” to tell her next sexual partner. 
Discussion 
 Fear of rejection is one of the most commonly reported fears and sources of 
anxiety for individuals with genital herpes (Bickford et al., 2007; Newton & McCabe, 
2008b; Shepherd, 2010).  However, rejection at last disclosure was not commonly 
reported among respondents in this sample.  Only 4% of participants who responded to 
the rejection items reported feeling rejected by their partner after their last disclosure.  
Interestingly, respondents who felt rejected did not necessarily report that their partner 
reacted negatively, indicating that these two concepts are not the same.  Two out of the 3 
participants who reported feeling rejected after the last disclosure reported that their 
partner reacted “somewhat positively” or “neither positively nor negatively”.  The 3 
participants who reported a negative partner response indicated they did not intend to 
have a future sexual partner.  The lack of negative reactions has important implications 
for health promotion messaging and decreasing psychosocial distress among this 
population, which are further described below. 
This study found that expectations of a partner’s response did not match outcomes 
of a disclosure.  Overall, disclosures were rated as unexpectedly positive.  Despite 
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expecting a somewhat negative reaction prior to disclosure, the majority of respondents 
reported that their partner reacted either neutrally or better.  Additionally, very few 
participants reported negative outcomes on the potential reactions index, with items 
regarding acting “more cautious” and “needed time to think about where the relationship 
was headed” having the most variability in answers among the potential negative reaction 
items.  Even these items were not commonly endorsed, as 47% and 45% of respondents 
strongly disagreed with these statements, respectively.  This supports research by Green 
and colleagues (2003), which found that the majority of participants reported “good” 
partner responses to a disclosure.  Beyond overall reaction ratings, the two most 
commonly agreed with partner reactions in the present study were also positive.  The 
majority of participants agreed with the statements regarding their partner being 
understanding and appreciating the honesty.  Research conducted with individuals 
without genital herpes whose partners disclosed to them corroborates these findings, as 
Williams (2009) found that male partners rated themselves as being understanding to 
their female partner’s disclosure and as appreciating their honesty. Reported reactions 
were far more positive than negative. 
There was little variability among the future intentions to disclose variable.  The 
majority of participants who left a possibility of a future sex partner reported being likely 
or very likely to disclose to their next partner.  Low levels of negative partner reactions 
may have influenced high intentions to disclose in the future.  However, previous work 
found high intentions for disclosure among young women with genital herpes without 
exploring past partner reactions (Barnack, 2011).  Together, these findings may indicate 
that intentions are high for disclosure regardless of past experiences, and characteristics 
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of future relationships are better predictors of disclosure with one’s next partner as 
opposed to prior reported intentions (Bickford et al., 2007; Green et al., 2003; Manuscript 
1). It is also not clear if intentions to disclose translates into the actual disclosure 
behavior.  Intentions to disclose were very high among this sample, with 85% of 
individuals reporting they were “Likely” or “Very likely” to disclose to their next sex 
partner.  However, studies of genital herpes disclosure and non-disclosure indicate that 
actual disclosure rates at last sex are typically lower than disclosure intentions (Green, 
2003; Manuscript 1). 
This study is not devoid of limitations. First, individuals self-selected to be part of 
a study about understanding sexual communication in relationships.  It is possible that 
individuals willing to complete a survey on sexual communication are more 
knowledgeable or more skilled at communicating about sexual topics.  As many of the 
participants were recruited through professional organizations that address human 
sexuality, this could potentially be true.  Findings may also be impacted by attrition; 
several respondents did not complete the questionnaire after they qualified for study 
inclusion, and these respondents could be characteristically different than those who 
completed the questionnaire.  However, approximately 84% of the qualifying sample 
completed at least some of the subsequent genital herpes specific questions.  The majority 
of the sample also reported being in a committed relationship of some type at their last 
disclosure.  These findings may not apply as well to more casual types of relationships, 
even though a variety of relationship types were represented.  Age may be another factor 
that could impact results; the mean age of the sample was 40 years old.  As Myers and 
colleagues (Manuscript 1) have previously established that age is an important individual 
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level predictor of disclosure, with younger individuals disclosing less, findings may not 
best represent experiences of adolescents and young adults who are commonly forming 
new relationships.  The low variability in future intentions to disclose may also be 
impacted by social desirability bias, as health professionals have stressed the importance 
of disclosure.   
However, individuals with genital herpes represent a hard to reach, highly 
stigmatized population without a robust sampling frame (Breitkopf, 2004).  To address 
this concern the research employed a study design that maximized reach while ensuring a 
higher level of anonymity through the utilization of an anonymous electronic 
questionnaire.  Additionally, the present study hosted the link to the questionnaire on a 
variety of online venues, including social networking sites such as Facebook, Twitter, 
and Reddit, as well as distributing the survey through a variety of professional and 
academic email lists to ensure a diverse sample of individuals with genital herpes and to 
address potential sample limitations of recruiting through herpes-specific and STI-
specific websites and communities highlighted by Newton & McCabe (2008a).  As such, 
this study explores numerous concepts previously not addressed in the disclosure 
literature using a unique methodology that does not over-sample from those heavily 
burdened either physically (clinics) or psychosocially (support groups).  It is also the 
largest sample of participants of both genders and the largest predominantly U.S. sample 
to date that examines genital herpes disclosure.  
This is the first study to our knowledge to explore the role of rejection and 
partner’s reaction in the disclosure process.  Findings confirm anecdotal and clinical 
experience highlighted on the American Sexual Health Association’s website about 
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disclosure (American Social Health Association, 2012).  Despite the common fear of 
rejection in this priority population, most respondents reported a successful disclosure 
that led to a continuation of the sexual relationship with few negative reactions. 
Additionally, most reported that their partner’s reaction was more positive than expected, 
with the majority of people expecting a somewhat negative reaction by their partner prior 
to disclosing.  Experiencing a more positive response than expected may have 
contributed to the high intentions to disclose in the future among those who intended to 
have a future sexual partner.  The influence of a positive disclosure experience on future 
intentions to disclose is supported by findings that positive first disclosure experiences of 
stigmatized identities are associated with less fear of future disclosure (Chaudior & 
Quinn, 2010).   
This study focused on the last disclosure experience, not necessarily one’s last sex 
partner.  Several participants indicated that they did not disclose to their last sexual 
partner, but had in the past.  This erratic pattern of disclosure could be attributed to one’s 
informal assessment of potential partner reactions.  Qualitative literature suggests that 
individuals are less likely to tell someone they expect would react negatively (Green et 
al., 2003; Lee & Craft, 2002), and Green and colleagues (2003) found that individuals 
were statistically less likely to disclose to their most recent partner.  The combination of 
these findings probably speaks to an informal evaluation of partner specific disclosure 
risks that someone with genital herpes conducts.   Previous disclosure research suggests 
that individuals with sexually transmitted infections assess and balance potential 
disclosure risks through a variety of internal and external processes (Derlega, Winstead, 
Greene, Serovich, & Elwood, 2004; Green et al., 2003; Lee & Craft, 2002; Moneyham et 
82 
 
al., 1996).  One strategy utilized to assess disclosure risk is to test a partner’s feelings 
about sexually transmitted infections broadly, or their infection specifically, before self-
identifying as an individual included among that group (Green et al., 2003; Lee & Craft, 
2002; Moneyham et al., 1996).  However, little is known about the accuracy of this 
internal risk assessment.  Findings from the current study indicate that disclosure reaction 
expectations are correlated with perceived reaction outcomes.  Collectively, these 
findings may provide evidence to suggest that individuals are accurately assessing 
partner’s demeanor and not disclosing to partners they believe would react more 
negatively.  As negative reactions were very low among this sample, partners reflected in 
the present study might be more amenable to this type of information than the pool of 
relationship possibilities and average response patterns.  
Future health behavior research should assess the extent to which individuals are 
able to accurately assess potential partner negativity to a disclosure to better understand 
the decision to disclose and its implications for psychosocial health.  Work by 
Zacharioudakis (2001) suggests that non-disclosure may be an important coping 
mechanism for individuals with high levels of psychosocial morbidity as a result of 
having genital herpes. Non-disclosers could be using the self-protecting coping strategy 
of non-disclosure strategically, potentially reducing the psychosocial impact of having 
their infection. However, individuals might be inaccurately assessing the potential 
negativity due to fear and stigma perceptions.   Participants in the present study often 
expected worse outcomes than they received.  Future studies should address the accuracy 
with which individuals make their disclosure/non-disclosure decision to assess potential 
avenues and strategies for intervention.  
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These findings have important health messaging implications for clinicians, 
therapists, and health educators, as common fears were not upheld, but rather debunked 
by the current study.  This is the first study to our knowledge to explore these 
relationships, and our results provide additional credibility and potential ease of mind for 
individuals with genital herpes who fear a disclosure encounter.  The disparity between 
expectations of a negative result and the relative positivity of most partners’ reactions 
might indicate that the majority of the psychosocial burden of genital herpes is self-
inflicted through stigma internalization rather than actual social interactions.  This truly 
speaks to the insidious nature of genital herpes stigma.  Findings from the present study 
are applicable to stigma reduction efforts which utilize cognitively-based interventions, 
especially expectation management strategies, to reduce existing psychosocial morbidity 
and increase disclosure behavior. Individuals using expectation management to decrease 
the psychosocial morbidity of genital herpes can report that responses from partners are 
not likely to be negative despite fears.  However, despite providing evidence to support 
genital herpes disclosure, it is important to note that findings from this exploratory study 
are not necessarily generalizable to other populations; negative responses to disclosure 
are also a possible outcome.  As such, future research should replicate this study with 
additional, diverse populations of individuals with genital herpes prior to applying the 
findings broadly to health messages. 
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Tables and Figures 
Table 1: Sample demographics 
Demographic Variable n % 
Sex (n = 86) 
  
 
Male 18 20.9 
 
Female 68 79.1 
Race/Ethnicity (n = 85) 
  
 
White 68 80.0 
 
Black/African American 3 3.5 
 
Hispanic/Latino 7 8.2 
 
Asian 4 4.7 
 
Native American 1 1.2 
 
Other 2 2.4 
Education (n = 86) 
  
 
High School / GED 1 1.2 
 
Some college 9 10.5 
 
2-year college degree 4 4.7 
 
4-year college degree 18 20.9 
 
Masters degree 32 37.2 
 
Doctoral degree 20 23.3 
 
Professional degree (JD, MD) 2 2.3 
Sexual Orientation (n =85) 
  
 
Heterosexual or straight 65 76.5 
 
Bisexual 13 15.3 
 
Homosexual, gay, or lesbian 3 3.5 
 
Other 4 4.7 
Country of Residence (n =85) 
  
 
United States 80 91.4 
 
Other 5 8.6 
Relationship Type (n = 75) 
  
 
Booty call 1 1.3 
 
Friends with benefits 6 8.0 
 
Dating 8 10.7 
 
Boyfriend/girlfriend 19 25.3 
 
Fiancé 3 4.0 
 
Husband/wife 32 42.7 
 
An ex 1 1.3 
 
Other 5 6.7 
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Table 1: Sample demographics (continued) 
Relationship Length (n= 69) 
  
 
Less than 1 week 2 2.9 
 
1 to 3 months 8 11.6 
 
4 to 6 months 6 8.7 
 
7 months to less than 2 years 7 10.1 
 
2 to 5 years 20 29.0 
 
6+ years 26 37.7 
Time known prior to disclosing (n= 69) 
  
 
Less than 1 week 12 17.4 
 
1 week to less than 1 month 10 14.5 
 
1 to 3 months 13 18.8 
 
4 to 6 months 8 11.6 
 
7 months to less than 2 years 12 17.4 
 
2 to 5 years 7 10.1 
 
6+ years 7 10.1 
    
Age (n = 86) M = 40.0 SD = 13.6 
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Table 2: Partner reactions at last disclosure 
After telling [my 
partner] that I had 
herpes, it seemed 
like he/she: n 
n 
NA 
Strongly 
disagree  
(1) 
Disagree 
(2) 
Neither 
agree nor 
disagree 
(3) 
Agree 
(4) 
Strongly 
Agree 
(5) Mean (SD) 
needed time to think 
about where the 
relationship was 
headed. 
64 5     45.3% 25.0%    14.1% 9.4%    6.3% 2.06   (1.25)  
was more cautious 
around me. 
67 3 47.0      25.8 13.6 12.1 1.5 1.95   (1.11)  
became awkward in 
intimate scenarios. 
66 3 53.0 28.8 12.1 1.5 4.5 1.76   (1.04) 
was not as interested 
in having sex. 
66 3 60.6 22.7 10.6 3.0 3.0 1.65   (1.00) 
was disgusted.  66 3 56.1 31.8   6.1 3.0 3.0 1.65   (0.95)  
did not touch me as 
much. 
64 5 62.5 21.9   9.4 3.1 3.1 1.63   (1.00) 
was not as passionate 
as they used to be. 
63 5 63.5 23.8   3.2 6.3 3.2 1.62   (1.04)  
found me less 
attractive. 
66 3 59.1 27.3 10.6      0 2.3 1.61   (0.91)  
kissed me less. 64 5 65.6 21.9   7.8 1.6 3.1 1.55   (0.94)  
was angry. 66 3 63.6 25.8   6.1 1.5 3.0 1.55   (0.91)  
contacted me less. 66 4 63.1 26.2   6.2 3.1 1.5 1.54   (0.87)  
wished I had never 
told them. 
65 3 64.6 26.2   6.2    0 3.1 1.51   (0.87) 
wanted to break up. 60 9 68.3 20.0   6.7 3.3 1.7 1.50   (0.89)  
Non-negative 
Responses   
 
            
was understanding. 67 1   3.0   1.5 11.9 43.3    40.3 4.16   (0.91) 
appreciated the 
honesty. 66 
3 
  3.0   3.0 16.7 31.8    45.5 4.14   (1.01) 
did not change the 
way they acted. 67 
2 
11.9 13.4   9.0 32.8    32.8 3.61   (1.38) 
trusted me more. 65 4   9.2 10.8 43.1 20.0    16.9 3.24   (1.15) 
made a bigger 
commitment to the 
relationship. 
62 
7 11.3 21.0 45.2 14.5      8.1 2.87   (1.06) 
didn't care. 67 2 23.9 19.4 23.9 22.4    10.4 2.76   (1.33) 
Note.  Numbers reported as percentages.  n NA means number reporting “Not Applicable”.  Responses of 
“Not Applicable” were recoded as missing.  Data was missing for this entire block of questions for 17 
participants. 
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Figure 1. Expectations of a partner’s response to a disclosure compared to the assessment 
of their partner’s reaction at last disclosure (n = 69).  Frequencies displayed.   
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Conclusion 
 This dissertation explored many components of genital herpes disclosure in two 
manuscripts.  The first manuscript addressed individual and partner characteristics as 
predictors of a genital herpes disclosure to one’s last sex partner.  It also examined 
reasons for disclosure and non-disclosure and disclosure timing.  The second manuscript 
examined past partner reactions to a disclosure and impacts on future intentions to 
disclose. 
 Overall, partner characteristics are better predictors of a disclosure versus non-
disclosure as opposed to individual level characteristics.  Only age was a significant 
individual level predictor of disclosure, with non-disclosers reporting a significantly 
younger mean age than disclosers.  However, relationship commitment, time in a 
relationship, and expectations of a partner’s reaction were all significant relationship 
characteristics at the bivariate level.  Relationship commitment and expectations of a 
partner’s reaction remained significant in logistic regression models.  Those in more 
socially committed, longer term relationships were more likely to have disclosed to their 
partner.  This supports previous findings that individuals are more likely to disclose to 
serious as opposed to casual partners across the sexual disclosure literature (Chaudior, 
Fisher, & Simoni; Green et al., 2003; McKay & Mutchler, 2011; Scrivener et al., 2008).   
Previous studies did not explore the statistical relationship between expectations 
and the decision to disclose.  With every one point increase in expected partner 
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negativity, the odds of disclosure decreased by 80%.  The distinction between expecting a 
negative response as opposed to a very negative response seems to have important 
ramifications on the decision to disclose and may trump other individual level factors that 
may facilitate a disclosure, such as respect for others and the desire to be honest.  Non-
disclosers expected their partner would react more negatively.  Similarly, fear of a partner 
reacting badly and fear of rejection were two of the primary reasons selected for non-
disclosure, which is consistent with other sexual disclosure literature (Derlega, Winstead, 
Greene, Serovich, & Elwood, 2004; Obermeyer, Baijal, & Pegurri, 2011; Scrivener et al., 
2008). As a partner’s right to know and honesty were commonly reported reasons for 
disclosure, future research should seek to model these characteristics at the individual 
level to see if a high desire to be honest or respect for others can override relationship 
characteristics in the decision to disclose.   
These findings have important implications for disclosure patterns, as many 
individuals choose to disclose to only some, but not all partners.  Understanding which 
factors have the most influence on the decisions to disclose may allow for better targeted 
health information about the need to disclose.  Many who did disclose did not disclose 
until after engaging in sexual activity with their partner.  The CDC (2010a) and ASHA 
(2012) recommend disclosing prior to engaging in sexual behavior that could potentially 
transmit genital herpes, indicating a need for programming to address two separate 
populations 1) those who decide not to disclose at all and 2) those who disclose after 
engaging in activities that could potentially transmit the virus.  
 Because relationship dynamics play an important role in the decision to disclose 
and expectations of a partner’s response is a key factor in the decisions to disclose, it is 
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important to understand how accurately individuals can predict partner response.  This 
dissertation found hints at mixed findings regarding this topic.  Despite the majority of 
individuals expecting a partner to react somewhat negatively after a disclosure, the 
overwhelming majority of individuals reported a more positive reaction than expected.  
This indicates that individuals may not be able to accurately assess potential partner 
responses.  On the other hand, those who did not decide to disclose were more likely to 
report that their partner would react VERY negatively than those who did disclose.  Half 
of non-disclosers at last sex had successfully disclosed in the past.  This may mean that 
their past partner gave signs and signals that indicated he or she would be more receptive 
to this type of disclosure.  Findings from prior herpes and HIV disclosure literature find 
that individuals often test the waters to see how a romantic or sexual partner might 
respond prior to disclosure (Derlega et al., 2004; Green et al., 2003).  This would support 
the idea that individuals with genital herpes are good at assessing who might react in a 
very negative way, including a rejection, and therefore protect themselves from this type 
of response by not disclosing.  In order to better understand whether individuals with 
genital herpes are able to accurately assess the risk of disclosure, future research is 
needed.  Furthermore, it is important to understand what would constitute a negative 
partner response and what a rejection would look like, as most people indicated a more 
positive reaction than expected.  As over 95% of the sample who disclosed reported a 
neutral to very positive partner response and non-rejection, future research should better 
capture what types of responses would exemplify these negative outcomes, in order to 
assess whether or not they are real or exacerbated negative expectations and to help form 
health education messages about realistic partner reactions.  It is important that inquiries 
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into this area ask about negative reactions and rejection separately, as these did not 
necessarily overlap, and rejection did not necessarily mean a relationship discontinuation.   
Theoretical Implications 
 Though internalized genital herpes stigma was not a significant individual level 
predictor of disclosure as explored in Manuscript 1, implications for Stigma Theory are 
still apparent in the totality of the dissertation research, especially in Manuscript 2.  First, 
the majority of individuals expected their partner to react somewhat negatively to their 
disclosure.  This expectation of a negative response likely comes from the societal 
perceptions of the infection.  However, what might be more important than one’s own 
perception of the stigma associated with genital herpes is their assessment of their 
partner’s beliefs about herpes stigma.  Individuals who expected their partner to react 
very negatively were less likely to disclose to their last sexual partner.  Additionally, the 
most common reasons reported for non-disclosure were shame, fear of rejection, and a 
partner reacting badly.  Though not included in the manuscript results, 77.6% of 
participants (n = 76) indicated that they either agreed or strongly agreed with the 
statement: “Since being diagnosed with genital herpes, I have realized that genital herpes 
is not that bad in the grand scheme of things.”  This supports past research that indicates 
that individuals cope with a diagnosis and come to terms with how the social stigma must 
now be incorporated with their own identity (Lee & Craft, 2002), and anxiety peaks at 
diagnosis and decreases over time (Miyai et al., 2004). As such, one’s personal beliefs 
about genital herpes may not be as indicative of how stigma plays a role in disclosure but 
rather how they perceive their partner feels about herpes might.   
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 Additionally, this research has implications for HIV disclosure theoretical 
development.  The Disclosure Processes Model, commonly discussed in HIV disclosure 
literature, is a framework used to understand when and why individuals with concealable 
stigmatizing identities disclose.  Though not currently applied to genital herpes in the 
literature, this study begins to measure one of the key constructs of the model, the 
feedback loop, which has been largely missing from the sexual disclosure literature 
(Chaudior, Fisher, & Simoni, 2011).  This study examines how past partner reactions are 
associated with future intentions to disclose.  Although statistically testing this 
relationship was not feasible due to sample limitations in the present study (i.e., 
inadequate number of participants who intended to have a future sex partner), the 
structure of the questionnaire provides one opportunity to examine this theoretical 
feedback relationship in future studies of sexual disclosure. 
Strengths and Weaknesses 
 One of the strengths of this study is that it quantified factors, such as fear of 
rejection, stigma, relationship seriousness, etc., highlighted in the qualitative literature to 
understand the relative importance of each of these factors.  This allowed for direct 
comparisons of previously identified themes and provided additional understanding of 
which themes were most commonly ascribed to in relation to each other and across 
studies.  This study also built on existing work by examining numerous individual and 
relationship characteristics previously unexplored in the qualitative and mixed methods 
research on genital herpes disclosure, such as outbreak frequency, suppressive medication 
use, and educational attainment.    
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Beyond simply generating items from themes in the literature, the questionnaire 
underwent a five phase pretesting process, including two phases which asked individuals 
with genital herpes to assess its sensitivity, validity, and comprehensiveness.  This 
iterative pretesting phase assisted in finessing existing items and adding response options 
that cognitive interviewees suggested were relevant.  Additionally, this multi-phase 
pretesting process highlighted potential areas of misunderstanding on key questions that 
impacted the survey flow and branching.  This resulted in additional clarifying wording 
and likely increased the reliability and validity of respondents’ answers. 
Another strength of this study was the recruitment technique.  Individuals in the 
present study were recruited from a broader base of internet sources as opposed to STI 
clinics (which typically include higher proportions of individuals who are symptomatic 
and/or newly diagnosed) or support groups (either electronic or in person, groups who 
likely have a higher burden of psychosocial distress).  Advertising the study as 
“Understanding Sexual Communication in Relationships” may have captured a different 
segment of individuals with genital herpes, specifically individuals who do not identify 
strongly with having the virus.  It also moves past recruiting from STI specific and herpes 
specific websites, as these individuals may need more support, information, or identify 
ore with the illness than individuals recruited through a more diversely used site, like 
Facebook.  Recruiting more broadly as a study about sexual communication also helped 
to ensure sample validity, as the true purpose of the research was not identified until after 
the individual filled out the screener.  As such, more diversity in the extent to which 
people identify with their herpes diagnosis might have been captured than in previous 
studies.   
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On the other hand, it is not clear if selection bias still impacted study findings.  Of 
the 110 individuals who met inclusion criteria, 105 agreed to take part when the nature of 
the study focused on genital herpes, and 96 of those individuals went on to actually fill 
out the questionnaire.  Therefore, perhaps individuals who had less negative experiences 
might have self-selected to continue participation.  Additionally, the majority of the 
sample was recruited on Facebook through personal contacts of the PI (a female) and 
through academic and professional email listservs.  As such, the sample was decidedly 
more White, female, and well educated than the population who has genital herpes at 
large.  Furthermore, as the majority of the listservs were dedicated to sexuality research, 
these individuals might be characteristically different than the population at large 
regarding communication about sexuality related topics, specifically stigmatized, taboo 
topics like genital herpes disclosure.  Because the study used the word “relationships” in 
the title, it might have also skewed the population towards individuals who are in 
committed relationships.  However, this was the largest study conducted with a primarily 
U.S. population regarding genital herpes disclosure.  As the online recruitment 
mechanism allows for greater geographical reach and is inexpensive, it facilitated 
generating a sizable sample compared to previous genital herpes studies, though it was 
still limited in size.  Future research should attempt to recruit more individuals of color, 
individuals of lower educational attainment, and younger individuals who are still 
actively dating to gain additional perspective.  Additionally, studies should prospectively 
follow newly diagnosed individuals to better understand disclosure patterns over time. 
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Summary 
  The dissertation research explored numerous themes throughout the genital 
herpes disclosure literature.  First, it builds on existing qualitative and mixed methods 
disclosure research, allowing for direct comparison of dominant disclosure themes 
highlighted previously in the literature.  This is the first study to examine the relative 
importance of reasons for disclosure and non-disclosure.  Additionally, this is the first 
research to explore outcomes of rejection and partner reaction. Surprisingly, the 
overwhelming majority of individuals reported a relatively positive response from their 
partner at last disclosure, low levels of rejection, and high intentions to disclose in the 
future, despite pervasive fears about rejection both in this study and previous research.  
These findings may help others coming to terms with a decision to disclose, knowing the 
likelihood of a negative reaction was very low among this group.  
This study begins to lay a research foundation for health education messages 
regarding genital herpes disclosure.   Existing health education messages regarding 
partner reactions to a genital herpes disclosure are largely based on professional 
experience and anecdotal evidence due to a limited research base on which to craft their 
messages.  Although findings from the present study corroborate existing health 
education messages about the positivity of a partner’s response made by ASHA, the 
leading educational and research organization in genital herpes psychosocial morbidity 
and disclosure, it is premature to suggest direct clinical or public health applications of 
the findings at the present time.  If these preliminary findings are confirmed with further 
research among more diverse samples, it might be appropriate for clinicians, therapists, 
and health educators to inform people living with genital herpes that negative reactions to 
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genital herpes disclosure are uncommon. This information could assist people living with 
genital herpes in managing their expectations of partners’ responses. As such, with 
further research and replication, there is potential for practical applications of this study’s 
findings to both public health education messaging and clinical management of 
psychosocial morbidity associated with genital herpes.  
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Appendix A: Questionnaire 
Online Questionnaire (exported survey from Qualtrics online survey software) 
 
Dissertation 2-14-14 For Launch 
Q1 Thank you for your interest in our research study Understanding Sexual 
Communication in Relationships (eIRB # 12595)!    Participation is voluntary.  There is 
information provided below to help you decide if you would like to participate.     
About the study:  We are interested in understanding how sexual communication can 
affect different types of relationships. More specifically, we are interested in how 
communication about sensitive topics has impacted you and your relationships.       
You are being asked to take part in a one-time survey online.        
There are no direct benefits from participating in the initial set of questions to see if you 
are an appropriate fit for the current study, but those who are an appropriate fit can be 
entered into a raffle to receive a $25 gift card.        
The brief survey to see if you are eligible should only take 5 minutes to complete.        
Results from this study may be published, but your name will not be associated with your 
answers.        
Your rights as a participant:  All of the information provided when taking part in this 
study will remain confidential. Your responses are also anonymous; the information you 
provide will not be linked to your name in any way. You may also stop the survey at any 
time or skip over questions you do not feel comfortable answering.   
If you ever have any questions, feel free to contact the Principal Investigator Jaime 
Myers, MPH at jmyers@health.usf.edu or the University of South Florida's Institutional 
Review Board at (813) 974-5638.   
Please click the Next button below if you are age 18 or older and you agree to take part in 
this survey.      
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Q2 Please answer the following questions to the best of your ability.  The following 
questions will determine if you are an appropriate candidate for the current study. 
 
Q3 Q) Where did you see the link to this study?  
 Facebook (1) 
 Twitter (2) 
 Email (3) 
 Reddit (5) 
 Other website:   Please explain below. (4) ____________________ 
 
Q4 Q) What is your sex? 
 Male (1) 
 Female (2) 
 Other (3) 
 
Q5 Q) What is your age?          ___________ 
 
Q6 Q) What country do you live in?
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 United States of 
America (1) 
 Afghanistan (2) 
 Albania (3) 
 Algeria (4) 
 Andorra (5) 
 Angola (6) 
 Antigua and 
Barbuda (7) 
 Argentina (8) 
 Armenia (9) 
 Australia (10) 
 Austria (11) 
 Azerbaijan (12) 
 Bahamas (13) 
 Bahrain (14) 
 Bangladesh (15) 
 Barbados (16) 
 Belarus (17) 
 Belgium (18) 
 Belize (19) 
 Benin (20) 
 Bhutan (21) 
 Bolivia (22) 
 Bosnia and 
Herzegovina (23) 
 Botswana (24) 
 Brazil (25) 
 Brunei Darussalam 
(26) 
 Bulgaria (27) 
 Burkina Faso (28) 
 Burundi (29) 
 Cambodia (30) 
 Cameroon (31) 
 Canada (32) 
 Cape Verde (33) 
 Central African 
Republic (34) 
 Chad (35) 
 Chile (36) 
 China (37) 
 Colombia (38) 
 Comoros (39) 
 Congo, Republic of 
the... (40) 
 Costa Rica (41) 
 Côte d'Ivoire (42) 
 Croatia (43) 
 Cuba (44) 
 Cyprus (45) 
 Czech Republic (46) 
 Democratic People's 
Republic of Korea 
(47) 
 Democratic 
Republic of the 
Congo (48) 
 Denmark (49) 
 Djibouti (50) 
 Dominica (51) 
 Dominican Republic 
(52) 
 Ecuador (53) 
 Egypt (54) 
 El Salvador (55) 
 Equatorial Guinea 
(56) 
 Eritrea (57) 
 Estonia (58) 
 Ethiopia (59) 
 Fiji (60) 
 Finland (61) 
 France (62) 
 Gabon (63) 
 Gambia (64) 
 Georgia (65) 
 Germany (66) 
 Ghana (67) 
 Greece (68) 
 Grenada (69) 
 Guatemala (70) 
 Guinea (71) 
 Guinea-Bissau (72) 
 Guyana (73) 
 Haiti (74) 
 Honduras (75) 
 Hong Kong (S.A.R.) 
(76) 
 Hungary (77) 
 Iceland (78) 
 India (79) 
 Indonesia (80) 
 Iran, Islamic 
Republic of... (81) 
 Iraq (82) 
 Ireland (83) 
 Israel (84) 
 Italy (85) 
 Jamaica (86) 
 Japan (87) 
 Jordan (88) 
 Kazakhstan (89) 
 Kenya (90) 
 Kiribati (91) 
 Kuwait (92) 
 Kyrgyzstan (93) 
 Lao People's 
Democratic 
Republic (94) 
 Latvia (95) 
 Lebanon (96) 
 Lesotho (97) 
 Liberia (98) 
 Libyan Arab 
Jamahiriya (99) 
 Liechtenstein (100) 
 Lithuania (101) 
 Luxembourg (102) 
 Madagascar (103) 
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 Malawi (104) 
 Malaysia (105) 
 Maldives (106) 
 Mali (107) 
 Malta (108) 
 Marshall Islands 
(109) 
 Mauritania (110) 
 Mauritius (111) 
 Mexico (112) 
 Micronesia, 
Federated States of... 
(113) 
 Monaco (114) 
 Mongolia (115) 
 Montenegro (116) 
 Morocco (117) 
 Mozambique (118) 
 Myanmar (119) 
 Namibia (120) 
 Nauru (121) 
 Nepal (122) 
 Netherlands (123) 
 New Zealand (124) 
 Nicaragua (125) 
 Niger (126) 
 Nigeria (127) 
 North Korea (128) 
 Norway (129) 
 Oman (130) 
 Pakistan (131) 
 Palau (132) 
 Panama (133) 
 Papua New Guinea 
(134) 
 Paraguay (135) 
 Peru (136) 
 Philippines (137) 
 Poland (138) 
 Portugal (139) 
 Qatar (140) 
 Republic of Korea 
(141) 
 Republic of 
Moldova (142) 
 Romania (143) 
 Russian Federation 
(144) 
 Rwanda (145) 
 Saint Kitts and 
Nevis (146) 
 Saint Lucia (147) 
 Saint Vincent and 
the Grenadines (148) 
 Samoa (149) 
 San Marino (150) 
 Sao Tome and 
Principe (151) 
 Saudi Arabia (152) 
 Senegal (153) 
 Serbia (154) 
 Seychelles (155) 
 Sierra Leone (156) 
 Singapore (157) 
 Slovakia (158) 
 Slovenia (159) 
 Solomon Islands 
(160) 
 Somalia (161) 
 South Africa (162) 
 South Korea (163) 
 Spain (164) 
 Sri Lanka (165) 
 Sudan (166) 
 Suriname (167) 
 Swaziland (168) 
 Sweden (169) 
 Switzerland (170) 
 Syrian Arab 
Republic (171) 
 Tajikistan (172) 
 Thailand (173) 
 The former 
Yugoslav Republic 
of Macedonia (174) 
 Timor-Leste (175) 
 Togo (176) 
 Tonga (177) 
 Trinidad and Tobago 
(178) 
 Tunisia (179) 
 Turkey (180) 
 Turkmenistan (181) 
 Tuvalu (182) 
 Uganda (183) 
 Ukraine (184) 
 United Arab 
Emirates (185) 
 United Kingdom of 
Great Britain and 
Northern Ireland 
(186) 
 United Republic of 
Tanzania (187) 
 Uruguay (189) 
 Uzbekistan (190) 
 Vanuatu (191) 
 Venezuela, 
Bolivarian Republic 
of... (192) 
 Viet Nam (193) 
 Yemen (580) 
 Zambia (1357) 
 Zimbabwe (781) 
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Q7 Q) What is your race/ethnicity?    You may check more than one option. 
 White/Caucasian (1) 
 Black/African American (2) 
 Hispanic/Latino (3) 
 Asian (4) 
 Native American (5) 
 Pacific Islander (6) 
 Other (7) ____________________ 
 
Q8 Q) What is the highest level of education you have completed? 
 Less than High School (1) 
 High School / GED (2) 
 Some College (3) 
 2-year College Degree (4) 
 4-year College Degree (5) 
 Masters Degree (6) 
 Doctoral Degree (7) 
 Professional Degree (JD, MD) (8) 
 
Q9 Q) What is your sexual orientation? 
 Heterosexual or straight (1) 
 Bisexual (2) 
 Homosexual, gay, or lesbian (3) 
 Other (4) ____________________ 
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Q10 Q)  Have you ever had any of the following? 
 Yes (1) No (2) 
chlamydia (1)     
gonorrhea (2)     
syphilis (4)     
genital herpes (5)     
human papillomavirus 
(HPV) (6)     
HIV infection or AIDS (9)     
 
Q32 According to the answers you provided above, you are a good fit for the current 
study.    One of the many factors that can impact sex, communication, and relationships is 
sexually transmitted diseases.   Genital herpes is one sexually transmitted disease that 
could influence communication in relationships.  Because so little is known about this 
topic, we would like to know more about your experiences with genital herpes and how it 
has impacted your relationships.  Would you be willing to answer some questions about 
these experiences with us?      
 Once again, your answers will NOT be associated with you; the survey is 
anonymous.  Your honesty and openness would be greatly appreciated.  We hope that the 
findings will be able to help individuals with genital herpes in the future.        
If you agree to take part in the survey, you can choose to be entered into a raffle to win a 
$25 gift certificate.  There will be 25 winners awarded.     The survey takes 
approximately 20 minutes to complete.      
Please indicate below if you would like to continue to participate in the study and click 
the Next button below.    
 I agree to participate. (1) 
 I do not wish to continue my participation. (2) 
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Q33 Q) Has a doctor or nurse ever told you that you had genital herpes? 
 Yes (1) 
 No (2) 
 Unsure (3) 
 
Q34 Q) How did you first realize that you had genital herpes? 
 I had symptoms that I was concerned about. (1) 
 I tested positive when I had a herpes blood test without ever experiencing symptoms 
first. (2) 
 Other (3) ____________________ 
 
Q35 Q) When did you find out that you had genital herpes?  If you are unsure, please 
provide your best guess.      
Month  (drop down boxes) 
Year   (drop down boxes) 
 
Q36 Q) Approximately how many sexual partners (both casual and/or serious) have you 
had since you were first told you had genital herpes?      Please enter a number in each 
box below.  If you are not sure, answer to the best of your ability. 
Vaginal Sex Partners (22) 
Oral Sex Partners (23) 
Anal Sex Partners (24) 
 
  
119 
 
Q37 We understand that telling others about having genital herpes can be particularly 
challenging.  There are many reasons why someone would or would share this 
information with others.   The following questions ask about your decisions to tell or not 
to tell others about having genital herpes.      
 
Q38 Q) Have you ever told someone that you were romantically or sexually interested in 
that you have genital herpes? 
 Yes (1) 
 No (2) 
 
Q39 Q) Have you ever told anyone that you have genital herpes?         This includes 
friends, family members, etc. 
 Yes (1) 
 No (2) 
 
Answer If P33) Approximately how many sexual partners (both casual and/or serious) 
have you had since you were... Vaginal Sex Partners Is Greater Than  0 Or P33) 
Approximately how many sexual partners (both casual and/or serious) have you had since 
you were... Oral Sex Partners Is Greater Than  0 Or P33) Approximately how many 
sexual partners (both casual and/or serious) have you had since you were... Anal Sex 
Partners Is Greater Than  0 
Q40 Q) Did you tell the last person you had sex with that you have genital 
herpes?     This includes oral, anal, or vaginal sex.  This could be at any point in your 
sexual relationship with this person- telling could have occurred before or after sex.  This 
could also be someone you are currently seeing.  
 Yes (1) 
 No, but I will definitely tell them in the future. (2) 
 No, but I might tell them in the future. (3) 
 No, and I don't plan to tell them. (4) 
 
Answer If P33) Approximately how many sexual partners (both casual and/or serious) 
have you had since you were... Vaginal Sex Partners Is Greater Than  0 Or P33) 
Approximately how many sexual partners (both casual and/or serious) have you had since 
you were... Oral Sex Partners Is Greater Than  0 Or P33) Approximately how many 
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sexual partners (both casual and/or serious) have you had since you were... Anal Sex 
Partners Is Greater Than  0 
Q41 Q) Which types of sex have you had with the last person you had sex with? 
 Yes (1) No (2) 
Vaginal Sex (1)     
Oral Sex (2)     
Anal Sex (3)     
 
 
Q42 Please think of the last time you told someone that you were romantically or 
sexually interested in about having genital herpes.    Please put a name, nickname, or 
initials for this person in the box below to help you answer future questions.         
EXAMPLE:  beach boy      
Whatever you write in the box will be used in future questions to help you answer 
them.   We will not be using this information otherwise.  The information you put below 
will show up underlined in future questions.        
If you do not put anything in the box below, there will be blanks in future questions. 
 
Q43 All of the questions on this page all refer to ${q://QID80/ChoiceTextEntryValue}.     
You identified this person as the last person you were sexually or romantically interested 
in who you told about having genital herpes in the previous box. 
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Q44 Q) Which types of sex have you had with ${q://QID80/ChoiceTextEntryValue}? 
 Yes (1) No (2) 
Vaginal Sex (1)     
Oral Sex (2)     
Anal Sex (3)     
 
 
Q45 Q) How would you best describe your relationship 
with ${q://QID80/ChoiceTextEntryValue} at the time you told them? 
 one night stand (1) 
 booty call (2) 
 friends with benefits (3) 
 dating (4) 
 boyfriend/girlfriend (5) 
 fiancé (6) 
 husband/wife (7) 
 an ex (8) 
 other (9) ____________________ 
 
122 
 
Q46 Q) Why did you decide to tell  ${q://QID80/ChoiceTextEntryValue} about having 
genital herpes?      
Below are some reasons that people decide to tell others about having genital 
herpes.  Please select “YES- Applies to Me” if the statement describes a reason that you 
decided to tell  ${q://QID80/ChoiceTextEntryValue} about having genital herpes or 
“NO- Does NOT apply” if it is not a reason you decided to tell. 
 YES 
Applies 
to Me 
(1) 
NO Does 
NOT 
apply (2) 
I thought they gave it to me. (1)     
I wanted to be honest. (2)     
I needed emotional support. (3)     
I expected my partner would be understanding. (4)     
I thought my partner would find out anyway. (5)     
I trusted my partner. (6)     
I felt guilty. (7)     
To protect my partner from getting herpes. (8)     
Because I had an outbreak. (9)     
I cared about my partner. (10)     
It is my partner’s right to know. (11)     
I had been drinking alcohol. (12)     
Our relationship became more serious. (13)     
My partner wanted to stop using condoms. (14)     
I felt bad about keeping a secret. (15)     
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Other (16)     
 
Q47 Below are the reasons you selected in the previous question as reasons you 
told ${q://QID80/ChoiceTextEntryValue} about having genital herpes.         
Q) Which of the following was the PRIMARY reason that you decided to 
tell ${q://QID80/ChoiceTextEntryValue} about having genital herpes? 
 
Q48 Q) Approximately how long had you 
known ${q://QID80/ChoiceTextEntryValue} before you told them about having genital 
herpes?     Please select the best option from the answers provided below. If you are 
unsure, please provide your best guess. 
 Less than 1 week (1) 
 1 week to less than 1 month (2) 
 1 to 3 months (3) 
 4 to 6 months (4) 
 7 months to less than 2 years (5) 
 2 to 5 years (6) 
 6+ years (7) 
 
Q49 Q) Approximately how long did or has your sexual or romantic relationship 
with ${q://QID80/ChoiceTextEntryValue} last(ed)?     Please select the best option from 
the answers provided below. If you are unsure, please provide your best guess.    
 Less than 1 week (1) 
 1 week to less than 1 month (2) 
 1 to 3 months (3) 
 4 to 6 months (4) 
 7 months to less than 2 years (5) 
 2 to 5 years (6) 
 6+ years (7) 
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Q50 Please fill in the box to answer each question with yes, no, not sure, or this activity 
never occurred with this person based on when you 
told ${q://QID80/ChoiceTextEntryValue} about having genital herpes.   
Example: If you told your partner about having genital herpes BEFORE your first kiss, 
you would select YES.    These items are not in a specific order and can occur, but are not 
expected to occur, in every type of relationship.      
Q) I told ${q://QID80/ChoiceTextEntryValue} about having genital herpes . . . 
 Yes 
(1) 
No 
(2) 
Not 
Sure 
(3) 
This 
activity 
never 
occurred 
with this 
person. 
(4) 
before the first kiss (1)         
before my partner touched my genitals with his or her 
hands (fingering/hand job) (8)         
before I touched my partner's genitals with my hands 
(fingering/hand job) (9)         
before my partner gave me oral sex (10)         
before I gave my partner oral sex (11)         
before we had vaginal sex (12)         
before we had anal sex (13)         
before the first date (2)         
before we both stopped seeing other people (became 
exclusive) (3)         
before I said, "I love you" (4)         
before they said, "I love you"" (5)         
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before we got engaged (6)         
before we got married (7)         
 
 
Q51 Q) Overall, how would you classify ${q://QID80/ChoiceTextEntryValue}’s reaction 
when you told them you had genital herpes? 
 Very positive (1) 
 Somewhat positive (2) 
 Neither positive nor negative (3) 
 Somewhat negative (4) 
 Very negative (5) 
 
Q52 Q) BEFORE you told ${q://QID80/ChoiceTextEntryValue} about having genital 
herpes, how did you EXPECT ${q://QID80/ChoiceTextEntryValue} to react? 
 Very positively (1) 
 Somewhat positively (2) 
 Neither positively or negatively (3) 
 Somewhat negatively (4) 
 Very negatively (5) 
 
Q53 Q) Did ${q://QID80/ChoiceTextEntryValue}’s reaction to telling them about having 
herpes make you feel rejected? 
 Yes (1) 
 No (2) 
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Q54 Q) After telling ${q://QID80/ChoiceTextEntryValue} that I had herpes, it seemed 
like ${q://QID80/ChoiceTextEntryValue}: 
 Strongl
y 
Disagre
e (1) 
Disa
gree 
(2) 
Neither 
Agree 
nor 
Disagre
e (3) 
Agre
e (4) 
Strong
ly 
Agree 
(5) 
Not 
Appli
cable 
(6) 
did not touch me as much. (1)             
was not as interested in having sex. 
(2)             
trusted me more. (3)             
wanted to break up. (4)             
kissed me less. (5)             
was not as passionate as they used 
to be. (6)             
appreciated the honesty. (7)             
needed time to think about where 
the relationship was headed. (8)             
was disgusted. (9)             
didn’t care. (10)             
was more cautious around me. (11)             
was angry. (12)             
did not change the way they acted. 
(13)             
contacted me less. (14)             
found me less attractive. (15)             
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made a bigger commitment to the 
relationship. (16)             
became awkward in intimate 
scenarios. (17)             
wished I had never told them. (18)             
was understanding. (19)             
 
 
Q55 Q) How would you best describe your relationship with the last person you had sex 
with at the time you last had sex? 
 one night stand (1) 
 booty call (2) 
 friends with benefits (3) 
 dating (4) 
 boyfriend/girlfriend (5) 
 fiance (6) 
 husband/wife (7) 
 an ex (8) 
 other (9) ____________________ 
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Q56 Q) Why did you decide to tell the last person you had sex with about having genital 
herpes?      
Below are some reasons that people decide to tell others about having genital 
herpes.  Please select “YES- Applies to Me” if the statement describes a reason that you 
decided to tell the last person you had sex with about your genital herpes or “NO- Does 
NOT apply” if it is not a reason you decided to tell. 
 YES 
Applies 
to Me 
(1) 
NO 
Does 
NOT 
apply 
(2) 
I thought they gave it to me. (1)     
I wanted to be honest. (2)     
I needed emotional support. (3)     
I expected my partner would be understanding. (4)     
I thought my partner would find out anyway. (5)     
I trusted my partner. (6)     
I felt guilty. (7)     
To protect my partner from getting herpes. (8)     
Because I had an outbreak. (9)     
I cared about my partner. (10)     
It is my partner’s right to know. (11)     
I had been drinking alcohol. (12)     
Our relationship became more serious. (13)     
My partner wanted to stop using condoms. (14)     
I felt bad about keeping a secret. (15)     
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Other (16)     
 
 
Q57 Below are reasons you selected in the previous question as reasons you decided to 
tell the last person you had sex with about having genital herpes.    Q) Which of the 
following is the PRIMARY reason you decided to tell the last person you had sex with 
that you have genital herpes?       
 
Q58 Q) Approximately how long had you known the last person you had sex with before 
you told them about having genital herpes?     Please select the best option from the 
answers provided below. If you are unsure, please provide your best guess. 
 Less than 1 week (1) 
 1 week to less than 1 month (2) 
 1 to 3 months (3) 
 4 to 6 months (4) 
 7 months to less than 2 years (5) 
 2 to 5 years (6) 
 6+ years (7) 
 
Q59 Q) Approximately how long did or has your sexual or romantic relationship with the 
last person you had sex with last(ed)?  Please select the best option from the answers 
provided below. If you are unsure, please provide your best guess.    
 Less than 1 week (1) 
 1 week to less than 1 month (2) 
 1 to 3 months (3) 
 4 to 6 months (4) 
 7 months to less than 2 years (5) 
 2 to 5 years (6) 
 6+ years (7) 
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Q60 Please fill in the box to answer each question with yes, no, or not applicable based 
on when you told the last person you had sex with about having genital herpes.    
Example: If you told your partner about having genital herpes BEFORE your first kiss, 
you would select YES.    These items are not in a specific order and can occur, but are not 
expected to occur, in every type of relationship.      
Q) I told the last person I had sex with about having genital herpes . . . 
 Yes 
(1) 
No 
(2) 
Not 
Sure 
(3) 
This 
activity 
never 
occurred 
with this 
person. 
(4) 
before the first kiss (1)         
before my partner touched my genitals with his or her 
hands (fingering/hand job) (8)         
before I touched my partner's genitals with my hands 
(fingering/hand job) (9)         
before my partner gave me oral sex (10)         
before I gave my partner oral sex (11)         
before we had vaginal sex (12)         
before we had anal sex (13)         
before the first date (2)         
before we both stopped seeing other people (became 
exclusive) (3)         
before I said, "I love you" (4)         
before they said, "I love you" (5)         
before we got engaged (6)         
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before we got married (7)         
 
 
Q61 Q) Overall, how would you classify the last person you had sex with&#39;s reaction 
when you told them you had genital herpes? 
 Very positive (1) 
 Somewhat positive (2) 
 Neither positive nor negative (3) 
 Somewhat negative (4) 
 Very negative (5) 
 
Q62 Q) BEFORE you told the last person you had sex with about having genital herpes, 
how did you EXPECT your partner to react to telling them? 
 Very positively (1) 
 Somewhat positively (2) 
 Neither positively or negatively (3) 
 Somewhat negatively (4) 
 Very negatively (5) 
 
Q63 Q) Did their reaction to telling them about having herpes make you feel rejected? 
 Yes (1) 
 No (2) 
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Q64 Q) After telling the last person I had sex with that I had herpes, it seemed 
like he/she: 
 Strongl
y 
Disagre
e (1) 
Dis
agr
ee 
(2) 
Neither 
Agree 
nor 
Disagree 
(3) 
Agre
e (4) 
Stron
gly 
Agre
e (5) 
Not 
Appl
icabl
e (6) 
did not touch me as much. (1)             
was not as interested in having sex. 
(2)             
trusted me more. (3)             
wanted to break up. (4)             
kissed me less. (5)             
was not as passionate as they used to 
be. (6)             
appreciated the honesty. (7)             
needed time to think about where the 
relationship was headed. (8)             
was disgusted. (9)             
didn’t care. (10)             
was more cautious around me. (11)             
was angry. (12)             
did not change the way they acted. 
(13)             
contacted me less. (14)             
found me less attractive. (15)             
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made a bigger commitment to the 
relationship. (16)             
became awkward in intimate 
scenarios. (17)             
wished I had never told them. (18)             
was understanding. (19)             
 
 
Q65 Q) Are you still having a romantic or sexual relationship with this person? 
 Yes (1) 
 No (2) 
 
Q66 Q) Is this the last person who you were sexually or romantically interested in that 
you told about your genital herpes? 
 Yes (1) 
 No (2) 
 
Q67 Q) In your opinion, how do you EXPECT the last person you had sex with would 
have reacted if you had told them about having genital herpes? 
 Very positively (1) 
 Somewhat positively (2) 
 Neither positively or negatively (3) 
 Somewhat negatively (4) 
 Very negatively (5) 
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Q68 Q)  Why did you decide not to tell the last person you had sex with about having 
genital herpes?      
Below are some reasons that people decide not to tell others about having genital 
herpes.  Please select “YES- Applies to Me” if the statement describes a reason that you 
decided not to tell or “NO- Does NOT apply” if it is not applicable to your situation. 
 YES 
Applies 
to Me 
(1) 
NO 
Does 
NOT 
apply (2) 
I was concerned my partner would react badly. (1)     
I was concerned that my partner would end the relationship. (2)     
It wasn't a serious relationship. (3)     
I was on daily herpes medication to prevent outbreaks. (4)     
I was ashamed. (5)     
It was none of my partner's business. (6)     
I was concerned that my partner would have rejected me. (7)     
I ended the relationship so that I didn't have to tell them. (8)     
I used condoms. (9)     
I was concerned that the information would spread to others. (10)     
We did not have vaginal or anal sex. (11)     
They didn't ask. (12)     
Other (13)     
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Q69 Below are reasons you selected in the previous question as reasons you decided not 
to tell the last person you had sex with about having genital herpes.    Q) Which of the 
following is the PRIMARY reason you decided not to tell the last person you had sex 
with that you have genital herpes? 
 
Q70 Q) How would you best describe your relationship with the last person you had sex 
with at the time you last had sex? 
 one night stand (1) 
 booty call (2) 
 friends with benefits (3) 
 dating (4) 
 boyfriend/girlfriend (5) 
 fiance (6) 
 husband/wife (7) 
 an ex (8) 
 other (9) ____________________ 
 
Q71 Q) Approximately how long did or has your sexual or romantic relationship last(ed) 
with this person?     Please choose the best option from the answers provided below.  If 
you are not sure, please provide your best guess. 
 Less than 1 week (1) 
 1 week to less than 1 month (2) 
 1 to 3 months (3) 
 4 to 6 months (4) 
 7 months to less than 2 years (5) 
 2 to 5 years (6) 
 6+ years (7) 
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Q72 This section of questions refers to activities that could or could not have occurred 
with the last person you had sex with.       
Q) Please select "Yes" for any item that did happen with the last person you had sex with 
or "No" for things that did not happen at any time in that relationship.   These items are 
not in a specific order and can occur, but are not expected to occur, in every type of 
relationship. 
 Yes (1) No 
(2) 
Not 
Sure 
(3) 
We kissed. (1)       
They touched my genitals with their hands (fingering/hand 
job). (8)       
I touched their genitals with my hands (fingering/hand job). 
(9)       
I gave them oral sex. (10)       
They gave me oral sex. (11)       
We had vaginal sex. (12)       
We had anal sex. (13)       
We had a first date. (2)       
We stopped seeing other people (became exclusive). (3)       
I said, "I love you". (4)       
They said, "I love you". (5)       
We got engaged. (6)       
We got married. (7)       
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Q73 Q) Are you still having a romantic or sexual relationship with this person? 
 Yes (1) 
 No (2) 
 
Q74 You are almost finished with the survey.   The following questions ask about your 
current experience with genital herpes. 
 
Q75 Q) Approximately how often do you have genital herpes outbreaks? 
 I have never had an outbreak or genital herpes symptoms. (1) 
 I haven't had an outbreak since my very first time getting genital herpes. (2) 
 Less than once a year. (3) 
 1 to 2 times a year (4) 
 3 to 5 times a year (5) 
 6 or more times a year (6) 
 
Q76 Q) Do you take any medication for genital herpes? 
 Yes, daily suppressive treatment to prevent outbreaks. (1) 
 Yes, when I notice signs of an outbreak or during an outbreak to shorten its length. 
(2) 
 No (3) 
 Other (4) ____________________ 
 
Answer If P33) Approximately how many sexual partners (both casual ... Vaginal Sex 
Partners Is Greater Than or Equal to  1 Or P33) Approximately how many sexual partners 
(both casual ... Anal Sex Partners Is Greater Than or Equal to  1 
Q77 Q) Since discovering you had genital herpes, how often have you used condoms 
when having anal or vaginal sex? 
 Never (1) 
 Rarely (2) 
 Sometimes (3) 
 Most of the time (4) 
 Always (5) 
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Q78 Q) Please indicate your current level of agreement with the following statements. 
 Strongly 
Disagree 
(1) 
Disagree 
(2) 
Neither 
Agree 
nor 
Disagree 
(3) 
Agree 
(4) 
Strongly 
Agree 
(5) 
I have been hurt by how people 
reacted to learning I have herpes. 
(1) 
          
I have stopped socializing with 
some people because of their 
reactions to my having herpes. (2) 
          
I have lost friends by telling them I 
have herpes. (3)           
I am very careful who I tell that I 
have herpes. (4)           
I worry that people who know I 
have herpes will tell others. (5)           
I feel that I am not as good a person 
as others because I have herpes. (6)           
Having herpes makes me feel 
unclean. (7)           
Having herpes makes me feel that 
I’m a bad person. (8)           
Most people think that a person 
with herpes is disgusting. (9)           
Most people with herpes are 
rejected when others find out. (10)           
I feel that I am not as sexually 
desirable as others because I have 
          
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herpes. (11) 
Having herpes makes me feel dirty 
in sexual situations. (12)           
 
 
Q79 Q) Since being diagnosed with genital herpes, I have . . . 
 Strongly 
Disagree 
(1) 
Disagree 
(2) 
Neither 
Agree 
nor 
Disagree 
(3) 
Agree 
(4) 
Strongly 
Agree 
(5) 
Learned more about my health. (1)           
Learned how to control my genital 
herpes. (2)           
Formed closer relationships with 
people who care about me. (3)           
Become a stronger person. (4)           
Realized that I have a lot of people 
who I can trust. (5)           
Realized that genital herpes is not 
that bad in the grand scheme of 
things. (6) 
          
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Q80 Q) How likely are you to tell your next sexual partner that you have genital herpes? 
 Very Unlikely (1) 
 Unlikely (2) 
 Likely (4) 
 Very Likely (5) 
 Undecided (3) 
 I do not intend on having another future sexual partner. (6) 
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Q81 Q) Overall, how honest were you in answering these questions?   
 Not honest at all (1) 
 Not very honest (2) 
 Fairly honest (3) 
 Very honest (4) 
 Completely honest (5) 
 
Q82 Is there anything else you would like to share about this experience? 
 
Q83 Thank you for taking the time to complete this survey!  I greatly appreciate your 
help.      
 When you click the ”Next” button below, your survey will be submitted and you will be 
automatically linked to a separate page so that you can either enter to win the $25 gift 
card or provide contact information if you would like to learn more about the study or 
participate in future studies.   We have you link to a separate survey so that your name 
and any other information you provide is not linked to the answers you provided 
above.       
Thank you again!      
Sincerely,  
 Jaime Myers, MPH   
jmyers@health.usf.edu 
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